<!DOCTYPE article
 PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.2 20190208//EN" "JATS-archivearticle1.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="preprint"><?all-math-mml yes?><?use-mml?><?origin ukpmcpa?><front><journal-meta><journal-id journal-id-type="nlm-ta">bioRxiv</journal-id><journal-title-group><journal-title>bioRxiv : the preprint server for biology</journal-title></journal-title-group><issn pub-type="epub">2692-8205</issn></journal-meta><article-meta><article-id pub-id-type="manuscript">EMS207036</article-id><article-id pub-id-type="doi">10.1101/2025.06.25.661454</article-id><article-id pub-id-type="archive">PPR1043283</article-id><article-version-alternatives><article-version article-version-type="status">preprint</article-version><article-version article-version-type="number">1</article-version></article-version-alternatives><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Advancing in silico drug design with Bayesian refinement of AlphaFold models</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Sen</surname><given-names>Samiran</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Hoff</surname><given-names>Samuel E.</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Morozova</surname><given-names>Tatiana I.</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="fn" rid="FN1">2</xref></contrib><contrib contrib-type="author"><name><surname>Schnapka</surname><given-names>Vincent</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Bonomi</surname><given-names>Massimiliano</given-names></name><xref ref-type="corresp" rid="CR1">*</xref><xref ref-type="aff" rid="A1">1</xref></contrib></contrib-group><aff id="A1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/0495fxg12</institution-id><institution>Institut Pasteur</institution></institution-wrap>, <institution-wrap><institution-id institution-id-type="ror">https://ror.org/05f82e368</institution-id><institution>Universitè Paris Citè</institution></institution-wrap>, <institution-wrap><institution-id institution-id-type="ror">https://ror.org/02feahw73</institution-id><institution>CNRS</institution></institution-wrap> UMR 3528, Computational Structural Biology Unit, <city>Paris</city>, <country country="FR">France</country></aff><author-notes><corresp id="CR1"><label>*</label><email>massimiliano.bonomi@pasteur.fr</email></corresp><fn id="FN1" fn-type="present-address"><label>2</label><p id="P1">Current address: CNRS, ENS de Lyon, LPENSL, UMR5672, 69342, Lyon cedex 07, France</p></fn></author-notes><pub-date pub-type="nihms-submitted"><day>11</day><month>07</month><year>2025</year></pub-date><pub-date pub-type="preprint"><day>27</day><month>06</month><year>2025</year></pub-date><permissions><ali:free_to_read/><license><ali:license_ref>https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref><license-p>This work is licensed under a <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">CC BY-NC-ND 4.0 International license</ext-link>.</license-p></license></permissions><abstract><p id="P2">Virtual screening has become an indispensable tool in modern structure-based drug discovery, enabling the identification of candidate molecules by computationally evaluating their potential to bind target proteins. The accuracy of such screenings critically depends on the quality of the target structures employed. Recent advances in protein structure prediction, particularly AlphaFold2, have revolutionized this field with unprecedented accuracy. However, AlphaFold2 models often exhibit limitations in local structural details, especially within binding pockets, which limit their utility for small molecule docking. In contrast, molecular dynamics simulations with accurate atomistic force fields can refine protein structures, but lack the ability to leverage the structural information provided by deep learning approaches. Here, we introduce bAIes, an integrative method that bridges this gap by combining physics-based force fields with data-driven predictions through Bayesian inference. bAIes enhances the structural accuracy of predicted models in regions most critical for ligand recognition. Crucially, bAIes demonstrates a superior ability to discriminate between binders and non-binders in virtual screening campaigns, outperforming both AlphaFold2 and molecular dynamics-refined models. By enhancing the usability of AlphaFold2 models without requiring extensive experimental or computational resources, bAIes offers a convenient solution to a longstanding challenge in structure-based drug design, potentially accelerating the early phases of drug discovery.</p></abstract></article-meta></front><body><sec id="S1" sec-type="intro"><title>Introduction</title><p id="P3">Structure-based drug design (SBDD) is a cornerstone of modern-day drug discovery, integrating high-resolution structural data with advanced computational techniques. The foundation of this approach lies in determining how small molecules bind to target biomolecules at the atomic level. This enables the design of molecules with high affinity, selectivity, and specific pharmacological profiles, advancing drug development in areas like oncology, infectious diseases, and neurodegenerative disorders.<sup><xref ref-type="bibr" rid="R1">1</xref></sup> In the context of SBDD, virtual screening (VS) has emerged as an efficient <italic>in silico</italic> approach to identify potential binders from large chemical libraries.<sup><xref ref-type="bibr" rid="R2">2</xref>–<xref ref-type="bibr" rid="R4">4</xref></sup> By prioritizing candidate molecules for synthesis and testing, this procedure accelerates experimental validation and subsequent lead optimization.<sup><xref ref-type="bibr" rid="R5">5</xref></sup> The key components of this process are: <italic>(i)</italic> a method for obtaining accurate, ligand-receptive structural models of the target protein;<sup><xref ref-type="bibr" rid="R6">6</xref>,<xref ref-type="bibr" rid="R7">7</xref></sup> <italic>(ii)</italic> a docking algorithm capable of efficiently exploring ligand binding poses;<sup><xref ref-type="bibr" rid="R8">8</xref></sup> and <italic>(iii)</italic> an accurate scoring function to rank poses and compare ligands.<sup><xref ref-type="bibr" rid="R9">9</xref>,<xref ref-type="bibr" rid="R10">10</xref></sup></p><p id="P4">In this work, we focus on the generation of accurate models of the target. Since determining an experimental structure is often challenging and time consuming, researchers frequently rely on computational models.<sup><xref ref-type="bibr" rid="R6">6</xref>,<xref ref-type="bibr" rid="R7">7</xref></sup> Comparative modeling has traditionally been used when experimental structures of homologous proteins with high sequence identity are available.<sup><xref ref-type="bibr" rid="R8">8</xref>,<xref ref-type="bibr" rid="R11">11</xref>–<xref ref-type="bibr" rid="R13">13</xref></sup> However, when the target lies in the twilight zone, <italic>i.e</italic>. with sequence identity below 30%, the reliability of comparative models drop drastically, and additional refinement becomes necessary. A potential solution to this problem came with the breakthrough in structure prediction by deep learning approaches such as AlphaFold2<sup><xref ref-type="bibr" rid="R14">14</xref></sup> (AF), which opened up new possibilities for targeting systems lacking both experimental structures and homologs with high sequence identity.<sup><xref ref-type="bibr" rid="R15">15</xref></sup> With AF, the availability of high-accuracy protein models was extended to the entire human proteome,<sup><xref ref-type="bibr" rid="R14">14</xref>,<xref ref-type="bibr" rid="R16">16</xref>,<xref ref-type="bibr" rid="R17">17</xref></sup> greatly expanding the scope of VS studies.</p><p id="P5">Using AF models in docking and VS studies, however, presents several challenges. One key issue is determining whether AF models, which are typically generated in absence of ligands, resemble more closely an <italic>apo</italic> (unbound) state, a <italic>holo</italic> (ligand-bound) state, or an intermediate between the two, as each conformation can have a distinct impact on docking performance. Although AF models generally display high structural accuracy, studies have shown that they often underperform compared to experimental <italic>holo</italic> structures when used as targets for docking.<sup><xref ref-type="bibr" rid="R18">18</xref></sup> In some cases, AF models identify top-ranking ligands with a success rate comparable to that of experimental <italic>apo</italic> structures, but they still perform worse than <italic>holo</italic> conformations.<sup><xref ref-type="bibr" rid="R19">19</xref></sup> These findings suggest that AF models may be more <italic>apo</italic>-like in nature. However, in a few instances, AF models have successfully identified binders that experimental structures could not, <sup><xref ref-type="bibr" rid="R20">20</xref></sup> implying that they might occasionally capture different <italic>holo</italic>-like conformations. Finally, in cases where experimental structures are not available, comparative models still perform generally better than AF, except for targets in the twilight zone.<sup><xref ref-type="bibr" rid="R21">21</xref></sup></p><p id="P6">In many of the instances mentioned above, the poor performance of AF models in docking and VS can be traced to inaccuracies in side chain conformations, such as steric clashes or unlikely rotamer states, <sup><xref ref-type="bibr" rid="R22">22</xref></sup> even when the backbone is predicted with high accuracy. Notably, significant discrepancies in side chain orientations between AF models and experimental structures have been reported. <sup><xref ref-type="bibr" rid="R18">18</xref>,<xref ref-type="bibr" rid="R23">23</xref></sup> Since docking performance is especially sensitive to the precise arrangement of side chains within the binding pocket,<sup><xref ref-type="bibr" rid="R24">24</xref>,<xref ref-type="bibr" rid="R25">25</xref></sup> even small errors can lead to incorrect predictions of ligand binding. Therefore, additional local refinement of AF models, particularly focused on side chain orientations, may be necessary to improve their utility and accuracy in SBDD. Several approaches have been developed to refine computational models with the goal of improving docking performance, with Molecular Dynamics (MD) simulations being one of the most popular approaches.<sup><xref ref-type="bibr" rid="R26">26</xref>–<xref ref-type="bibr" rid="R30">30</xref></sup> These methods generally focus on local stereochemistry refinement through extensive MD simulations, typically with weak restraints on the initial model.<sup><xref ref-type="bibr" rid="R31">31</xref>,<xref ref-type="bibr" rid="R32">32</xref></sup> However, despite these advances, existing methods do not consistently translate into improved docking outcomes, one of the main reasons being the inherent inaccuracies in the molecular mechanics force field used.<sup><xref ref-type="bibr" rid="R33">33</xref>,<xref ref-type="bibr" rid="R34">34</xref></sup></p><p id="P7">In this work, we introduce bAIes, a method that combines Alphafold2 predictions with state-of-the-art molecular mechanics force fields. At the core of this integration, bAIes quantifies the local uncertainties in an AF model and uses a Bayesian inference framework to optimally combine the structural information provided by this tool with accurate physico-chemical descriptions of the system. Here, we focus on applying bAIes to refine ligand binding pocket conformations and assess the ability of these refined models to predict accurate ligand poses in docking. Furthermore, we evaluate the performance of bAIes in identifying binders through screening of large small molecule libraries. bAIes consistently outperforms AF and MD models by ranking binders significantly higher than non-binders. Overall, we show that bAIes is able to provide a principled path toward making AF structural models truly actionable for drug discovery.</p></sec><sec id="S2"><title>Theory</title><p id="P8">In integrative structural biology, Bayesian modeling approaches are used to combine diverse experimental data with physico-chemical knowledge to generate accurate and precise structural models of biological systems. To optimally integrate different sources of information, these methods explicitly model uncertainties and errors, allowing each piece of data to be weighted according to its reliability. Similarly, bAIes models the uncertainty in structural information provided by AlphaFold2 (AF) using distograms, which are distance distributions between <italic>C</italic><sub><italic>β</italic></sub> atoms (or <italic>C</italic><sub><italic>α</italic></sub> atoms for glycines). Distograms measure the local confidence of the AF model and are used in the structure module to guide model generation. Consequently, the most probable <italic>C</italic><sub><italic>β</italic></sub>–<italic>C</italic><sub><italic>β</italic></sub> distance in a distogram typically matches closely the corresponding distance in the final predicted structure.</p><p id="P9">Generally speaking, Bayesian inference methods estimate the probability of a model <italic>M</italic>, defined in terms of its structure <bold>X</bold> and other parameters, given the information available about the system, including prior physico-chemical knowledge and newly acquired data. The posterior probability <italic>p</italic>(<italic>M</italic> | <italic>D</italic>) of model <italic>M</italic> given data <italic>D</italic> and prior knowledge, is expressed as: <disp-formula id="FD1"><label>(1)</label><mml:math id="M1"><mml:mrow><mml:mi>p</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mi>M</mml:mi><mml:mo>∣</mml:mo><mml:mi>D</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mo>∝</mml:mo><mml:mi>p</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mi>D</mml:mi><mml:mo>∣</mml:mo><mml:mi>M</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mo>⋅</mml:mo><mml:mi>p</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mi>M</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></disp-formula> where the likelihood function <italic>p</italic>(<italic>D</italic> | <italic>M</italic>) represents the probability of observing data <italic>D</italic> given <italic>M</italic>. This function quantifies the agreement between the observed data and the model and accounts for all sources of uncertainty and error in the data. The term <italic>p</italic>(<italic>M</italic>) is the probability of model <italic>M</italic> based on prior knowledge. In the following, we specify each component of this general Bayesian framework as applied in our bAIes approach.</p><sec id="S3"><title>The data</title><p id="P10">In integrative structural biology applications, <italic>D</italic> = {<italic>d</italic><sub><italic>i</italic></sub>} represents a collection of experimental data points, often originating from different techniques, such as NMR, <sup><xref ref-type="bibr" rid="R35">35</xref></sup> SAXS,<sup><xref ref-type="bibr" rid="R36">36</xref></sup> or cryo-electron microscopy.<sup><xref ref-type="bibr" rid="R37">37</xref></sup> In bAIes, <italic>D</italic> represents the structural information provided by AF, defined as a collection of distances between <italic>C</italic><sub><italic>β</italic></sub> atoms (or <italic>C</italic><sub><italic>α</italic></sub> in the case of glycines). Each data point <italic>d</italic><sub><italic>i</italic></sub> represents the most probable distance computed from the corresponding AF distogram. Distances between residues separated in sequence by less than 3 aminoacids were discarded. Additionally, a residue-pair specific cutoff <sup><xref ref-type="bibr" rid="R38">38</xref></sup> was applied to retain only those residue pairs whose distances are indicative of potential inter-residue interactions.</p></sec><sec id="S4"><title>Data likelihood</title><p id="P11">For each pair of selected residues, a log-normal likelihood was used: <disp-formula id="FD2"><label>(2)</label><mml:math id="M2"><mml:mrow><mml:mi>p</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mi>d</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>∣</mml:mo><mml:mstyle mathvariant="bold" mathsize="normal"><mml:mi>X</mml:mi></mml:mstyle><mml:mo>,</mml:mo><mml:msub><mml:mi>σ</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:mfrac><mml:mn>1</mml:mn><mml:mrow><mml:msub><mml:mi>d</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:msub><mml:mi>σ</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:msqrt><mml:mrow><mml:mn>2</mml:mn><mml:mi>π</mml:mi></mml:mrow></mml:msqrt></mml:mrow></mml:mfrac><mml:mtext>exp</mml:mtext><mml:mrow><mml:mo>[</mml:mo><mml:mrow><mml:mo>−</mml:mo><mml:mfrac><mml:mrow><mml:msup><mml:mrow><mml:mtext>ln</mml:mtext></mml:mrow><mml:mn>2</mml:mn></mml:msup><mml:mfrac><mml:mrow><mml:msub><mml:mi>d</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo stretchy="false">(</mml:mo><mml:mstyle mathvariant="bold" mathsize="normal"><mml:mi>X</mml:mi></mml:mstyle><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mrow><mml:msub><mml:mi>d</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mrow></mml:mfrac></mml:mrow><mml:mrow><mml:mn>2</mml:mn><mml:msubsup><mml:mi>σ</mml:mi><mml:mi>i</mml:mi><mml:mn>2</mml:mn></mml:msubsup></mml:mrow></mml:mfrac></mml:mrow><mml:mo>]</mml:mo></mml:mrow></mml:mrow></mml:math></disp-formula> where <italic>d</italic><sub><italic>i</italic></sub>(<bold>X</bold>) is the distance between a pair of residues in structure <bold>X</bold>, <italic>d</italic><sub><italic>i</italic></sub> the most probable distance in the corresponding AF distogram, and <italic>σ</italic><sub><italic>i</italic></sub> an error parameter that modulates the deviation between observed and computed data. Under the assumption of independent data points, the total likelihood for a set of of <italic>m</italic> points <italic>D</italic> = {<italic>d</italic><sub><italic>i</italic></sub>} can be factorized as: <disp-formula id="FD3"><label>(3)</label><mml:math id="M3"><mml:mrow><mml:mi>p</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi>D</mml:mi><mml:mo>∣</mml:mo><mml:mstyle mathvariant="bold" mathsize="normal"><mml:mi>X</mml:mi></mml:mstyle><mml:mo>,</mml:mo><mml:mrow><mml:mo>{</mml:mo><mml:mrow><mml:msub><mml:mi>σ</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mrow><mml:mo>}</mml:mo></mml:mrow></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:mstyle displaystyle="true"><mml:munderover><mml:mo>∏</mml:mo><mml:mrow><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mi>m</mml:mi></mml:munderover><mml:mrow><mml:mi>p</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mi>d</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>∣</mml:mo><mml:mstyle mathvariant="bold" mathsize="normal"><mml:mi>X</mml:mi></mml:mstyle><mml:mo>,</mml:mo><mml:msub><mml:mi>σ</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:mstyle></mml:mrow></mml:math></disp-formula></p></sec><sec id="S5"><title>Priors</title><p id="P12">In bAIes, the error parameters <italic>σ</italic><sub><italic>i</italic></sub> are treated as unknown variables and are determined by sampling the posterior distribution. To penalize large errors, we used an informative Jeffreys prior:<sup><xref ref-type="bibr" rid="R39">39</xref></sup> <disp-formula id="FD4"><label>(4)</label><mml:math id="M4"><mml:mrow><mml:mi>p</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mi>σ</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:mfrac><mml:mn>1</mml:mn><mml:mrow><mml:msub><mml:mi>σ</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mrow></mml:mfrac></mml:mrow></mml:math></disp-formula></p><p id="P13">Additionally, the width of the corresponding distogram, calculated by fitting this distribution with a log-normal-like function, was used as the minimum value <inline-formula><mml:math id="M5"><mml:mrow><mml:msubsup><mml:mi>σ</mml:mi><mml:mi>i</mml:mi><mml:mrow><mml:mtext>min</mml:mtext></mml:mrow></mml:msubsup></mml:mrow></mml:math></inline-formula> for each uncertainty parameter. This choice allows us to handle cases where AF predictions are inaccurate in the same way we would treat outlier experimental data points in other Bayesian inference approaches for structural biology. Atomistic molecular mechanics force fields <italic>E</italic><sub>FF</sub> were used as structural prior: <disp-formula id="FD5"><label>(5)</label><mml:math id="M6"><mml:mrow><mml:mi>p</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mstyle mathvariant="bold" mathsize="normal"><mml:mi>X</mml:mi></mml:mstyle><mml:mo stretchy="false">)</mml:mo><mml:mo>∝</mml:mo><mml:mtext>exp</mml:mtext><mml:mrow><mml:mo>[</mml:mo><mml:mrow><mml:mo>−</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>E</mml:mi><mml:mrow><mml:mtext>FF</mml:mtext></mml:mrow></mml:msub><mml:mo stretchy="false">(</mml:mo><mml:mstyle mathvariant="bold" mathsize="normal"><mml:mi>X</mml:mi></mml:mstyle><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mrow><mml:msub><mml:mi>k</mml:mi><mml:mi>B</mml:mi></mml:msub><mml:mi>T</mml:mi></mml:mrow></mml:mfrac></mml:mrow><mml:mo>]</mml:mo></mml:mrow></mml:mrow></mml:math></disp-formula></p></sec><sec id="S6"><title>Marginalization</title><p id="P14">To avoid sampling the <italic>σ</italic><sub><italic>i</italic></sub> parameters, we marginalized the corresponding likelihood distributions along with their uncertainty priors. For each data point, the resulting marginal data likelihood is: <disp-formula id="FD6"><label>(6)</label><mml:math id="M7"><mml:mrow><mml:mi>p</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mi>d</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>∣</mml:mo><mml:mstyle mathvariant="bold" mathsize="normal"><mml:mi>X</mml:mi></mml:mstyle></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:msubsup><mml:mrow><mml:mstyle displaystyle="true"><mml:mo>∫</mml:mo></mml:mstyle></mml:mrow><mml:mrow><mml:msubsup><mml:mi>σ</mml:mi><mml:mi>i</mml:mi><mml:mrow><mml:mtext>min</mml:mtext></mml:mrow></mml:msubsup></mml:mrow><mml:mi>∞</mml:mi></mml:msubsup><mml:mi>p</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mi>d</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>∣</mml:mo><mml:mstyle mathvariant="bold" mathsize="normal"><mml:mi>X</mml:mi></mml:mstyle><mml:mo>,</mml:mo><mml:msub><mml:mi>σ</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mi>p</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mi>σ</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mn>0.5</mml:mn></mml:mrow><mml:mrow><mml:msub><mml:mi>d</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mtext>ln</mml:mtext><mml:mfrac><mml:mrow><mml:msub><mml:mi>d</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mi>d</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo stretchy="false">(</mml:mo><mml:mstyle mathvariant="bold" mathsize="normal"><mml:mi>X</mml:mi></mml:mstyle><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mfrac></mml:mrow></mml:mfrac><mml:mtext>erf</mml:mtext><mml:mrow><mml:mo>[</mml:mo><mml:mrow><mml:mfrac><mml:mrow><mml:mtext>ln</mml:mtext><mml:mfrac><mml:mrow><mml:msub><mml:mi>d</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mi>d</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo stretchy="false">(</mml:mo><mml:mstyle mathvariant="bold" mathsize="normal"><mml:mi>X</mml:mi></mml:mstyle><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mfrac></mml:mrow><mml:mrow><mml:msqrt><mml:mn>2</mml:mn></mml:msqrt><mml:msubsup><mml:mi>σ</mml:mi><mml:mi>i</mml:mi><mml:mrow><mml:mtext>min</mml:mtext></mml:mrow></mml:msubsup></mml:mrow></mml:mfrac></mml:mrow><mml:mo>]</mml:mo></mml:mrow></mml:mrow></mml:math></disp-formula></p></sec><sec id="S7"><title>The bAIes hybrid energy function</title><p id="P15">After defining all the components of our approach and marginalizing the uncertainty parameters, we obtain the final bAIes posterior distribution: <disp-formula id="FD7"><label>(7)</label><mml:math id="M8"><mml:mrow><mml:mi>p</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mstyle mathvariant="bold" mathsize="normal"><mml:mi>X</mml:mi></mml:mstyle><mml:mo>∣</mml:mo><mml:mi>D</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mo>∝</mml:mo><mml:mstyle displaystyle="true"><mml:munderover><mml:mo>∏</mml:mo><mml:mrow><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mi>m</mml:mi></mml:munderover><mml:mrow><mml:mi>p</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mi>d</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>∣</mml:mo><mml:mstyle mathvariant="bold" mathsize="normal"><mml:mi>X</mml:mi></mml:mstyle></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>⋅</mml:mo><mml:mi>p</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mstyle mathvariant="bold" mathsize="normal"><mml:mi>X</mml:mi></mml:mstyle><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mstyle></mml:mrow></mml:math></disp-formula> where the marginal data likelihood is given by <xref ref-type="disp-formula" rid="FD6">Eq. 6</xref> and the structural prior by <xref ref-type="disp-formula" rid="FD5">Eq. 5</xref>. To sample the posterior, we define the associated bAIes hybrid energy function as: <disp-formula id="FD8"><label>(8)</label><mml:math id="M9"><mml:mrow><mml:msub><mml:mi>E</mml:mi><mml:mrow><mml:mtext>bAIes</mml:mtext></mml:mrow></mml:msub><mml:mo stretchy="false">(</mml:mo><mml:mstyle mathvariant="bold" mathsize="normal"><mml:mi>X</mml:mi></mml:mstyle><mml:mo stretchy="false">)</mml:mo><mml:mo>=</mml:mo><mml:mo>−</mml:mo><mml:msub><mml:mi>k</mml:mi><mml:mi>B</mml:mi></mml:msub><mml:mi>T</mml:mi><mml:mspace width="0.2em"/><mml:mtext>log</mml:mtext><mml:mspace width="0.2em"/><mml:mi>p</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mstyle mathvariant="bold" mathsize="normal"><mml:mi>X</mml:mi></mml:mstyle><mml:mo>∣</mml:mo><mml:mi>D</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mo>=</mml:mo><mml:msub><mml:mi>E</mml:mi><mml:mrow><mml:mtext>FF</mml:mtext></mml:mrow></mml:msub><mml:mo stretchy="false">(</mml:mo><mml:mstyle mathvariant="bold" mathsize="normal"><mml:mi>X</mml:mi></mml:mstyle><mml:mo stretchy="false">)</mml:mo><mml:mo>+</mml:mo><mml:msub><mml:mi>E</mml:mi><mml:mrow><mml:mtext>AF</mml:mtext></mml:mrow></mml:msub><mml:mo stretchy="false">(</mml:mo><mml:mstyle mathvariant="bold" mathsize="normal"><mml:mi>X</mml:mi></mml:mstyle><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></disp-formula>which is composed of the molecular mechanics force field <italic>E</italic><sub>FF</sub> and the spatial restraints <italic>E</italic><sub>AF</sub> that incorporate the structural information provided by the AF distograms. Finally, models are sampled by MD under the bAIes hybrid energy function defined in <xref ref-type="disp-formula" rid="FD8">Eq. 8</xref>. In summary, during a bAIes simulation, the standard MD force field is modified by spatial restraints centered on the most probable distance predicted by AF and with intensities reflecting the AF confidence in the model (<xref ref-type="fig" rid="F1">Fig. 1</xref>). Distograms with wide distributions result in weak structural restraints, while narrow distributions suggesting high confidence of AF in the model are translated into strong restraints.</p></sec></sec><sec id="S8" sec-type="results"><title>Results</title><p id="P16">This section is organized as follows. First, we assess the accuracy of bAIes in refining the structure of ligand binding sites starting from AF models. We then evaluate whether bAIes models can be used in combination with docking protocols to <italic>i)</italic> accurately reproduce the native ligand poses observed in experimental structures; and <italic>ii)</italic> discriminate between binders and non-binders during virtual screening of large libraries of small molecules (<xref ref-type="fig" rid="F1">Fig. 1</xref>).</p><sec id="S9"><title>Structural accuracy of ligand binding pockets</title><p id="P17">We evaluated the accuracy and precision of bAIes-refined ligand-binding pockets using a benchmark set of 15 proteins, whose structures in complex with their native ligands were determined by X-ray crystallography at high resolution (1.5 <italic>−</italic> 3.2Å, <xref ref-type="supplementary-material" rid="SD1">Table S1</xref>). This benchmark set is composed of systems of varying complexity, including soluble and transmembrane proteins, nuclear and cytoplasmic proteins, as well as monomeric and multimeric assemblies. To quantify model quality, we calculated the Root Mean Square Deviation (RMSD) of the <italic>C</italic><sub><italic>β</italic></sub> atoms of the ligand pocket from the corresponding experimental structure (<xref ref-type="sec" rid="S13">Methods</xref>). The quality of bAIes-optimized pockets was compared to both the original AF models as well as with pockets obtained by refining the AF models with standard MD simulations.</p><p id="P18">The quality of AF models in the binding pocket ranged from excellent to poor, with RMSDs spanning from 0.33Å in the case of the estrogen receptor (PDB 2AM9) to 2.95Å in the case of thymidine kinase (PDB 2UZ3) and with mean value equal to 1.13Å (<xref ref-type="supplementary-material" rid="SD1">Fig. S1</xref>, gray). We quantified the local level of confidence in the pocket region using the average pLDDT score across the binding pocket residues (binding pocket pLDDT). This was appreciably high, with values in most cases greater than 90, indicating that AF modeled these regions with high confidence. Notably, pockets that deviated significantly from the experimental structure, such as thymidine kinase, were not necessarily the ones with lowest binding pocket pLDDT. Overall, these results indicate that, in the majority of cases, the AF binding pocket is structurally very similar to the experimental one, as also seen in previous studies. <sup><xref ref-type="bibr" rid="R18">18</xref>,<xref ref-type="bibr" rid="R40">40</xref></sup></p><p id="P19">To evaluate the accuracy of the structural models generated by MD, we first analyzed the distributions of pocket RMSDs along each trajectory. Across the entire benchmark set, these RMSDs covered a broad range from excellent to poor, with values spanning from a minimum of 0.48Å for the estrogen receptor (PDB 2AM9) to a maximum of 3.78Å for thymidine kinase (PDB 2UZ3) (<xref ref-type="supplementary-material" rid="SD1">Fig. S1</xref>, orange). These two systems exhibited also the lowest and highest average pocket RMSD per trajectory <inline-formula><mml:math id="M10"><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mover accent="true"><mml:mrow><mml:mtext>RMSD</mml:mtext></mml:mrow><mml:mo stretchy="true">¯</mml:mo></mml:mover><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></inline-formula>, with values equal to 0.72Å and 3.29Å, respectively. Overall, the average <inline-formula><mml:math id="M11"><mml:mrow><mml:mover accent="true"><mml:mrow><mml:mtext>RMSD</mml:mtext></mml:mrow><mml:mo stretchy="true">¯</mml:mo></mml:mover></mml:mrow></mml:math></inline-formula> across all the systems in our benchmark set was only 0.51Å higher than the average RMSD of the AF models.</p><p id="P20">Substantial structural variability of the binding pocket was also observed in all MD simulations. This variability is reflected in the width of the RMSD distribution within each trajectory. The narrowest and widest RMSD ranges were observed for the estrogen receptor (PDB 2AM9) and nucleoside phosphorylase (PDB 3BGS), with values of 0.54Å and 2.02Å, respectively. Notably, in only 47% of cases the MD simulations sampled conformations closer to the reference experimental structure than the AF model. In these successful cases, the fraction of conformations within each trajectory that had pocket RMSDs lower than AF ranged from 0.1% (Dopamine <italic>D</italic><sub>3</sub> receptor, PDB 3PBL) to 12.5% (Estrogen receptor <italic>α</italic>, PDB 3ERD).</p><p id="P21">The ligand binding pockets generated by bAIes were found to be systematically closer to the experimental one than MD (<xref ref-type="supplementary-material" rid="SD1">Fig. S1</xref>, blue). Specifically, both the most accurate and least accurate bAIes models were superior to the corresponding MD models, as reflected in the smallest (estrogen receptor, PDB 2AM9, 0.33Å) and largest (phosphodiesterase 5A, PDB 1UDT, 3.29Å) pocket RMSD values. The <inline-formula><mml:math id="M12"><mml:mrow><mml:mover accent="true"><mml:mrow><mml:mtext>RMSD</mml:mtext></mml:mrow><mml:mo stretchy="true">¯</mml:mo></mml:mover></mml:mrow></mml:math></inline-formula> per trajectory ranged from 0.44Å (estrogen receptor, PDB 2AM9) to 3.01Å (thymidine kinase, PDB 2UZ3). The average <inline-formula><mml:math id="M13"><mml:mrow><mml:mover accent="true"><mml:mrow><mml:mtext>RMSD</mml:mtext></mml:mrow><mml:mo stretchy="true">¯</mml:mo></mml:mover></mml:mrow></mml:math></inline-formula> across all bAIes trajectories was only 0.16Å higher than the average AF RMSDs, and 0.34Å lower than the average MD RMSDs.</p><p id="P22">Across all bAIes trajectories, the structural variability of the binding pockets was significantly lower compared to standard MD simulations. On average, the width of the pocket RMSD distribution was 0.43Å, less than half of that observed in MD trajectories (0.96Å). The narrowest and widest RMSD ranges for bAIes were found for the <italic>β</italic><sub>2</sub> adrenergic receptor (PDB 4LDO) and leukocyte-function associated antigen 1 (PDB 2ICA), with values of 0.20Å and 0.70Å, respectively. Notably, bAIes was more frequently able to sample pocket conformations that were closer to the experimental structure than the AF model, achieving this in 87% of cases, compared to 47% for MD. Among these successful cases, the fraction of sampled conformations within each trajectory with pocket RMSDs lower than AF ranged from 0.1% (fatty-acid-binding protein 4, PDB 2NNQ and dopamine <italic>D</italic><sub>3</sub> receptor, PDB 3PBL) to 15.2% (hexokinase type IV, PDB 3F9M).</p><p id="P23">In all the analysis reported in this section, we compared our models to a single experimental <italic>holo</italic> structure. We intentionally excluded from the comparison both backbone and side-chain atoms (other than <italic>C</italic><sub><italic>β</italic></sub>) to capture similarities with other <italic>holo</italic> structures that exhibit minor structural variations, particularly in side-chain orientations, with respect to the selected experimental structure. However, it is still possible that the original AF model, as well as the MD- and bAIes-refined conformations, resembled more closely a different <italic>holo</italic> structure. To test this hypothesis, we selected three systems (PDBs 3ERD, 3BGS, and 1H00) for which multiple <italic>holo</italic> structures in complex with different ligands were available (<xref ref-type="table" rid="T1">Table 1</xref>). In each case, the AF model was more similar to a <italic>holo</italic> structure different from the one initially chosen for comparison (<xref ref-type="fig" rid="F2">Fig. 2</xref>). Furthermore, while bAIes models were consistently closer than MD models to the most similar <italic>holo</italic> structure, fewer distinct <italic>holo</italic> structures were identified as their closest matches compared to those found by MD. These observations will be useful for interpreting the performance in native ligand docking and virtual screening reported in the following sections.</p></sec><sec id="S10"><title>Structural accuracy of native ligand docking poses</title><p id="P24">Accurate ligand poses are crucial in docking because they directly influence the reliability of structure-based drug discovery efforts, including virtual screening, binding affinity estimation, and rational design of molecular modifications. Inaccurate poses can mislead subsequent optimization steps and mask potential binding interactions. Here we evaluate the impact of target structure refinement on docking accuracy. To do this, we docked the (native) ligands from our benchmark set of 15 systems (<xref ref-type="supplementary-material" rid="SD1">Table S1</xref>) to the original AF model as well as to selected bAIes- and MD-refined conformations. Typically, multiple docking poses (up to 9) were generated, usually differing in energy values of <italic>~</italic> 1kcal mol<sup><italic>−</italic>1</sup> between the highest and lowest scored models. Docking success was measured by computing the minimum ligand RMSD (RMSD<sub><italic>l</italic></sub>) between the reference experimental <italic>holo</italic> structure and the top five poses ranked by the docking scoring function (<xref ref-type="sec" rid="S13">Methods</xref>). A docking trial was considered successful when the RMSD<sub><italic>l</italic></sub> was below 2Å.</p><p id="P25">Re-docking the native ligands to their corresponding experimental <italic>holo</italic> structures was consistently successful (<xref ref-type="fig" rid="F3">Fig. 3a</xref>, pink). All systems yielded RMSD<sub><italic>l</italic></sub> below 2Å, with 33% achieving values below 1Å, confirming the validity of our docking protocol <sup><xref ref-type="bibr" rid="R41">41</xref></sup> (<xref ref-type="fig" rid="F3">Fig. 3b</xref>, pink). In contrast, docking native ligands to the AF models was successful in 40% of cases (<xref ref-type="fig" rid="F3">Fig. 3a</xref>, gray). For these systems, RMSD<sub><italic>l</italic></sub> ranged from 0.81 to 1.72Å, with an average of 1.39Å (<xref ref-type="fig" rid="F3">Fig. 3a</xref>, gray). The most accurate pose was obtained for the estrogen receptor (PDB 2AM9), while the least accurate was observed for the progesterone receptor (PDB 3KBA). In all but one case, docking to the AF models produced less accurate poses compared to re-docking to the experimental <italic>holo</italic> structures. The sole exception was purine nucleoside phosphorylase (PDB 3BGS), where the AF model yielded a lower RMSD<sub><italic>l</italic></sub> (0.88Å) than the experimental structure (1.13Å).</p><p id="P26">For both MD and bAIes models, each trajectory was first clustered based on structural similarity. A representative structure from each of the three most populated clusters was selected as a target for docking trials (<xref ref-type="sec" rid="S13">Methods</xref>, <xref ref-type="supplementary-material" rid="SD1">Fig. S2</xref>). Finally, the most accurate ligand pose among the top five ranked poses across the three representative structures was selected. In the case of MD, successful docking was observed in only 13% of the systems (<xref ref-type="fig" rid="F3">Fig. 3a</xref>, orange). In these successful cases, the RMSD<sub><italic>l</italic></sub> ranged from 0.64 to 1.58Å, with an average of 1.11Å, slightly better than the results obtained with AF models (<xref ref-type="fig" rid="F3">Fig. 3b</xref>, orange). However, unlike with AF, docking to MD models consistently produced less accurate poses than re-docking to the experimental structures. The best result was achieved for the estrogen receptor (PDB 2AM9), while the worst was observed for the progesterone receptor (PDB 3KBA).</p><p id="P27">For bAIes-refined models, successful docking was observed in 33% of the systems (<xref ref-type="fig" rid="F3">Fig. 3a</xref>, blue). The RMSD<sub><italic>l</italic></sub> ranged from 0.68 to 1.75Å, with an average of 1.48Å, closely matching the performance of AF models (<xref ref-type="fig" rid="F3">Fig. 3b</xref>, blue). In 80% of the successful cases, the accuracy of the poses was higher than MD (<xref ref-type="fig" rid="F3">Fig. 3b,d</xref>), but, in all cases, lower than that obtained by re-docking to the experimental structures. The most accurate docking pose was observed for the estrogen receptor, while the least accurate was for the urokinase-type plasminogen activator (PDB 1SQT).</p><p id="P28">Overall, we employed 3 different ways to model protein structures: AF, bAIes, and MD. In the following, we want to explore the possibility of combining these methods or a subset of them to maximize the chances of success in docking native ligands. We first noticed that MD docking was never successful in cases where either AF or bAIes failed (<xref ref-type="fig" rid="F3">Fig. 3c</xref>). Furthermore, in cases where one of these two methods was successful, MD produced the most accurate pocket structure only 25% of the times. Based on these considerations, we tested a combination of only AF and bAIes as follows. First, we collected the scores of docked ligands from both the AF model and bAIes clusters, and then re-ranked all of them based on these scores. As before, we identified the most accurate pocket structure from the top five ranked poses. However, this approach yielded success rates similar to those of the individual methods alone, suggesting that combining data from bAIes and AF docking does not provide any particular advantage. This somewhat disappointing result can largely be attributed to the limitations of the scoring function, which was not always capable of ranking the most accurate poses highly.</p></sec><sec id="S11"><title>Virtual screening of small molecule libraries</title><p id="P29">In real-life drug discovery campaigns, docking is primarily used to screen large libraries of small molecules against protein targets, often with unknown <italic>holo</italic> structures, to identify potential binders. For such task, the ability to reliably discriminate binders from non-binders is often more critical than achieving highly accurate docking poses, as the ultimate goal is to prioritize candidates for experimental validation rather than to precisely model binding interactions. In this section, we assess the ability of bAIes to discriminate between binders and non-binders. To do so, we selected three systems and docked large libraries of ligands containing both binders and decoys (<xref ref-type="sec" rid="S13">Methods</xref>). For each system, we screened the libraries against AF, MD, and bAIes models as well as one experimental <italic>holo</italic> structure, which is generally considered more suitable for virtual screening than an <italic>apo</italic> conformation. <sup><xref ref-type="bibr" rid="R42">42</xref></sup> The three selected targets were the estrogen receptor <italic>α</italic> (PDB 3ERD), the purine nucleoside phosphorylase (PDB 3BGS), and the cyclin-dependent kinase (PDB 1H00), which were screened against a total of 58409 small molecules, of which 1422 were known binders (<xref ref-type="fig" rid="F4">Fig. 4a</xref>).</p><p id="P30">In order to quantify the performance of each method used to model the target, we used two metrics: the receiver operating characteristic (ROC) curve<sup><xref ref-type="bibr" rid="R43">43</xref></sup> and the linear-log ROC (pROC) curve.<sup><xref ref-type="bibr" rid="R44">44</xref></sup> Briefly, the ROC curve characterizes how well a method can distinguish between true positives (actual binders) and false positives (non-binders) as the score threshold (or rank) for selecting molecules is varied. The area under the ROC curve (ROC-AUC) provides a single measure of this performance: a larger AUC indicates a better ability to rank true binders ahead of non-binders, with an AUC of 1.0 representing perfect classification and 0.5 representing random guessing. The pROC curve extends this idea by placing greater emphasis on the early part of the ranking, which is particularly important in virtual screening contexts where only the top-ranked compounds are typically tested. <sup><xref ref-type="bibr" rid="R45">45</xref>,<xref ref-type="bibr" rid="R46">46</xref></sup> Therefore, a larger area under the pROC curve (pROC-AUC) reflects a method’s effectiveness in identifying true binders among the top-scoring candidates.</p><p id="P31">First, we observed that, for all the three targets studied, both the experimental structure (<xref ref-type="fig" rid="F4">Fig. 4b</xref>, pink) as well as the AF (<xref ref-type="fig" rid="F4">Fig. 4b</xref>, gray), MD (<xref ref-type="fig" rid="F4">Fig. 4b</xref>, orange), and bAIes (<xref ref-type="fig" rid="F4">Fig. 4b</xref>, blue) models had a ROC-AUC larger than a random classifier (<xref ref-type="fig" rid="F4">Fig. 4b</xref>, dotted gray). Furthermore, the experimental structures showed excellent discriminatory power, with average ROC-AUC and pROC-AUC of 0.79 and 1.24, respectively. The AF models also performed well (average ROC-AUC of 0.76), but showed early enrichment consistently lower than that obtained using the experimental structure (average pROC-AUC of 1.03). Notably, in the case of the estrogen receptor <italic>α</italic>, the AF ROC-AUC of 0.74 was slightly superior to the experimental one of 0.73, though the early enrichment was still poorer (pROC-AUC of 1.21 compared to 1.28).</p><p id="P32">In the case of MD and bAIes, the target models were selected by clustering the trajectories in the same way as for native ligand docking (<xref ref-type="sec" rid="S13">Methods</xref>). Due to the large computational cost, only the center of the most populated cluster was used for the virtual screening. The ROC-AUCs obtained with the MD model were consistently worse than the experimental ones by 2.7%, 13.5% and 4.1% for PDB 3ERD, 3BGS, 1H00, respectively. The pROC-AUCs were also significantly lower than the experimental ones by 19.5%, 45.6% and 16.5% for PDB 3ERD, 3BGS, and 1H00, respectively (<xref ref-type="table" rid="T2">Table 2</xref>). When comparing with AF, the performance varied across systems. The MD ROC-AUC was worse for PDB 3ERD and 3BGS (by 4.1% and 8.3%, respectively) and so were the corresponding pROC-AUCs (by 14.9% and 25.9%, respectively). For the third system (PDB 1H00), the MD ROC-AUC and pROC-AUC were slightly better than AF (by 1.4% and 2.5%, respectively) (<xref ref-type="table" rid="T2">Table 2</xref>).</p><p id="P33">Remarkably, bAIes models had a higher enrichment than the experimental structures for two of our targets (by 2.7% and 1.4% for PDB 3ERD and 1H00, respectively), but worse in the other case (by 3.4% for PDB 3BGS). However, pROC-AUCs were consistently worse than the experimental ones by 3.9%, 21.1% and 3.1% for PDB 3ERD, 3BGS, and 1H00, respectively (<xref ref-type="table" rid="T2">Table 2</xref>). In comparison with the AF model, bAIes consistently showed better discriminatory performance across all systems studied (ROC-AUC higher by 1.4%, 2.4% and 7.1% for PDB 3ERD, 3BGS, and 1H00, respectively). Notably, the early enrichments were significantly better, with pROC-AUC higher by 1.7%, 7.4% and 19.0% for PDB 3ERD, 3BGS, and 1H00, respectively (<xref ref-type="table" rid="T2">Table 2</xref>).</p><p id="P34">When compared to MD, bAIes consistently produced significantly higher ROC-AUC (by 5.6%, 11.7% and 5.6% for PDB 3ERD, 3BGS, and 1H00, respectively) as well as superior pROC-AUC (by 19.4%, 45.0% and 16.0% for PDB 3ERD, 3BGS and 1H00, respectively). Notably, the bAIes improvement in early enrichment with respect to both MD and AF is 2 to 5 times the improvement observed in the overall discriminative capacity. This indicates that, in absence of available experimental structures, bAIes is the best single approach for obtaining early enrichment compared to both MD and AF models.</p><p id="P35">Although both AF and MD showed inferior performance in early enrichment, it is worth exploring whether the distinct conformations generated by these methods enabled the identification of some specific binders that bAIes failed to capture. To investigate this, we calculated the number of unique ligands identified by each method across the three systems studied, as a function of the ranking selection threshold. We found that the AF model was able to capture ligands not identified by bAIes in two out of three cases (PDB 3BGS and 3ERD), though in lower but still significant numbers (<xref ref-type="fig" rid="F4">Fig. 4c</xref>); in the third case (PDB 1H00) bAIes outperformed AF. On the other hand, bAIes consistently identified a significantly higher number of unique ligands compared to MD (<xref ref-type="fig" rid="F4">Fig. 4d</xref>). These observations suggest that, when sufficient computational resources are available, using both AF and bAIes models as target structures in virtual screening campaigns may be a valuable strategy to identify a diverse set of ligands for experimental testing.</p></sec></sec><sec id="S12" sec-type="discussion"><title>Discussion</title><p id="P36">In this work, we introduce bAIes, a Bayesian modeling framework that leverages the structural information provided by AF to refine atomistic protein models for use in virtual screening of small molecules. bAIes combines the structural information encoded in AF distograms with state-of-the-art molecular mechanics force fields employed in molecular dynamics simulations (Theory). Notably, in our virtual screening benchmarks, bAIes-refined models consistently outperformed both the original AF predictions and conformations refined using standard MD. In particular, our models demonstrated a superior ability to distinguish binders from non-binders, especially among the top-scoring ligands. This enhanced early enrichment is critical in real-world virtual screening campaigns, where only the highest-ranked compounds are typically selected for experimental validation.</p><p id="P37">Our results suggest that bAIes is able to sample conformations that are close to the initial AF models, representative of local structural fluctuations of the target, and suitable for ligand binding. In principle, such conformations should also be accessible through standard MD simulations. However, limitations in the underlying MD force fields may hinder the sampling of these conformations. By integrating the pairwise distance distributions provided by AF, we were able to overcome these limitations. An intriguing interpretation of these findings is that distograms provide not only a measure of confidence in the AF predictions, but also encode information about protein fluctuations, and thus about the (thermo)dynamics of the target. This idea is supported by our recent work, <sup><xref ref-type="bibr" rid="R47">47</xref></sup> in which we used bAIes to determine accurate atomistic structural ensembles of intrinsically disordered proteins. These ensembles were validated against extensive sets of solution experimental data, showing excellent agreement and thus supporting the idea that AF distograms can capture dynamic properties of the system and thus used to characterize protein conformational distributions.</p><p id="P38">We also evaluated the ability of bAIes to refine ligand-binding pockets and to improve the accuracy of native ligand docking poses. In this context, we obtained mixed results. In our benchmark composed of 15 systems, bAIes sampled conformations closer to the reference experimental structures than the original AF models in only 67% of cases. Furthermore, the success rate for docking native ligands was comparable to that obtained using the original AF models. While our results were always superior to those obtained with MD-refined models, they did not demonstrate a clear advantage over directly using the AF-generated structures. However, it remains to be systematically assessed whether AF and bAIes captured <italic>holo</italic>-like (or <italic>apo</italic>) conformations that differ from the one that we designated as reference structure. This would explain the performances observed both when assessing the accuracy of the ligand-binding pockets and with the native ligand docking. The analysis of three systems in our benchmark set seemed to support this hypothesis (<xref ref-type="table" rid="T1">Table 1</xref>).</p><p id="P39">To overcome some of the limitations described above, several potential improvements to bAIes can be envisioned. First, in this work, we performed only short simulations to refine the models. In the future, thanks to the integration of bAIes into the open-source PLUMED library,<sup><xref ref-type="bibr" rid="R48">48</xref>,<xref ref-type="bibr" rid="R49">49</xref></sup> it will be straightforward to combine our method with enhanced sampling techniques, such as metadynamics, to access conformations further distant from the initial AF models. Second, in this study, conformations for docking or virtual screening were selected solely based on cluster populations. Moving forward, conformations generated by bAIes could be rescored using scoring functions and consensus strategies specifically designed to identify druggable conformations.<sup><xref ref-type="bibr" rid="R50">50</xref>–<xref ref-type="bibr" rid="R52">52</xref></sup> Finally, docking protocols and scoring functions play a critical role in correctly ranking compounds. We foresee a more systematic evaluation of bAIes performances using a broader range of docking approaches, particularly new methods based on deep learning.<sup><xref ref-type="bibr" rid="R53">53</xref>,<xref ref-type="bibr" rid="R54">54</xref></sup></p><p id="P40">In this work, we used distograms generated by AlphaFold2, as the source code for AlphaFold3 (AF3) was not available at the time we developed our approach, and distogram information could not be retrieved from the AF3 web server. Now that the source code has been released, it is possible to obtain AF3 distograms, which could further expand the range of applications for bAIes. For example, bAIes could be employed to refine RNA models for use in virtual screening. Targeting RNAs with small molecules is an exciting and rapidly growing field of research,<sup><xref ref-type="bibr" rid="R55">55</xref>,<xref ref-type="bibr" rid="R56">56</xref></sup> attracting increasing interest from pharmaceutical companies. Moreover, AF3 now allows for modeling protein and RNA targets in complex with small molecules. The poses obtained with AF3 could be further refined with bAIes by integrating distograms that describe target-ligand distance distributions. It would be interesting to assess whether bAIes-refined models of small molecule–protein complexes improve ligand pose accuracy or virtual screening enrichment. Nevertheless, limitations in the usage and licensing of AF3 outputs may complicate further development of bAIes based on this new version of the software.</p><p id="P41">In conclusion, bAIes provides a computationally efficient approach to refine AlphaFold2 models of protein targets for their use in the early stages of drug design. The method is implemented in the PLUMED-ISDB module<sup><xref ref-type="bibr" rid="R57">57</xref></sup> of the open-source PLUMED library (<ext-link ext-link-type="uri" xlink:href="http://www.plumed.org">www.plumed.org</ext-link>),<sup><xref ref-type="bibr" rid="R48">48</xref>,<xref ref-type="bibr" rid="R49">49</xref></sup> making it readily accessible to a large computational science community. Our approach has the potential to improve the reliability of virtual screening campaigns by prioritizing compounds with a higher likelihood of success. As such, it offers a valuable addition to modern drug discovery pipelines, where the availability of accurate target models remains a key bottleneck. Ultimately, bAIes can contribute to the development of more effective and selective therapeutic candidates.</p></sec><sec id="S13" sec-type="methods"><title>Methods</title><sec id="S14"><title>AlphaFold2 model generation</title><p id="P42">To generate the AF models, the complete FASTA sequence of each target protein (<xref ref-type="supplementary-material" rid="SD1">Table S1</xref>) was fed into AlphaFold2 v2.3.2.<sup><xref ref-type="bibr" rid="R14">14</xref></sup> The multimer model was used, and MSA searches were conducted with HHBlits<sup><xref ref-type="bibr" rid="R58">58</xref></sup> and HHSearch<sup><xref ref-type="bibr" rid="R59">59</xref></sup> on BFD<sup><xref ref-type="bibr" rid="R14">14</xref></sup> and Uniref30 (until 30-02-2023) databases, and with Jackhmmer from HMMER3<sup><xref ref-type="bibr" rid="R60">60</xref></sup> on Uniref90<sup><xref ref-type="bibr" rid="R61">61</xref></sup> and clustered MGnify<sup><xref ref-type="bibr" rid="R62">62</xref></sup> databases. All genetic databases (full databases) used at CASP14 were searched for optimizing the structures. Default templates (until 14-05-2020) were used to guide the structure predictions. A single seed per model was used to make 5 predictions that were ranked according to their model confidences, measured by the predicted LDDT (pLDDT). The top ranked model was relaxed with gradient descent by OpenMM using the AMBER99SB<sup><xref ref-type="bibr" rid="R63">63</xref></sup> force field and selected for further analysis.</p></sec><sec id="S15"><title>Molecular dynamics and bAIes simulations</title><p id="P43">All simulations were performed with GROMACS v2022.5<sup><xref ref-type="bibr" rid="R64">64</xref></sup> equipped with PLUMED v2.9.<sup><xref ref-type="bibr" rid="R48">48</xref></sup></p><sec id="S16"><title>Setup and equilibration</title><p id="P44">For soluble proteins, the AF models were solvated in a cubic box, with dimensions chosen to ensure that its boundaries were at least 1.0nm away from any modeled atom. Na<sup>+</sup> and Cl<sup><italic>−</italic></sup> ions were added at a concentration of 0.15M to neutralize the net system charge. The AMBER99SB-ILDN <sup><xref ref-type="bibr" rid="R65">65</xref></sup> force field and TIP3P model<sup><xref ref-type="bibr" rid="R66">66</xref></sup> were used for protein and water molecules, respectively. Equations of motion were integrated with a standard leap-frog algorithm with a timestep of 1fs. Van der Waals interactions were gradually switched off at 0.8nm and cut off at 0.9nm; the fast smooth particle-mesh Ewald (PME) method was used to calculate electrostatic interactions with cutoff at 0.9nm.<sup><xref ref-type="bibr" rid="R67">67</xref></sup> Energy-minimization was performed on the solvated structures with the steepest-descent algorithm. This was followed by relaxation first under NVT conditions for 100ps to a target temperature of 300K. The Bussi-Donadio-Parrinello thermostat<sup><xref ref-type="bibr" rid="R68">68</xref></sup> was used with a time constant of 0.2ps. The systems were then equilibrated in the NPT ensemble for 100ps to a target pressure of 1bar using an isotropic Berendsen barostat<sup><xref ref-type="bibr" rid="R69">69</xref></sup> with coupling time constant of 1ps. During both NVT and NPT equilibration, harmonic restraints were applied to the positions of the protein heavy atoms, with force constant equal to 1000kJ mol<sup><italic>−</italic>1</sup> nm<sup><italic>−</italic>2</sup>.</p><p id="P45">For membrane proteins (PDB 4LDO and 3PBL), the AF models were first oriented in an implicit lipid bilayer parallel to the <italic>xy</italic> plane using the PPM 3.0 webserver,<sup><xref ref-type="bibr" rid="R70">70</xref></sup> and then used as input for CHARMM-GUI.<sup><xref ref-type="bibr" rid="R71">71</xref></sup> The systems were inserted in a homogeneous POPC lipid bilayer and solvated in a triclinic box. Na<sup>+</sup> and Cl<sup><italic>−</italic></sup> ions were added at a concentration of 0.15M to neutralize the net system charge. The CHARMM36m<sup><xref ref-type="bibr" rid="R72">72</xref></sup> and mTIP3P model<sup><xref ref-type="bibr" rid="R73">73</xref></sup> were used for protein/lipids and water molecules, respectively. Van der Waals interactions were gradually switched off at 1.0nm and cut off at 1.2nm; PME was used to calculate electrostatic interactions with cutoff at 1.2nm.<sup><xref ref-type="bibr" rid="R67">67</xref></sup> The standard CHARMM-GUI protocol was used to equilibrate the systems. Multiple consecutive short simulations in the NVT and NPT ensembles at a temperature of 303.15K and pressure of 1bar were performed to equilibrate the systems. The Bussi-Donadio-Parrinello thermostat<sup><xref ref-type="bibr" rid="R68">68</xref></sup> was used with a time constant of 0.2ps. For the NPT runs, a semi-isotropic Berendsen barostat<sup><xref ref-type="bibr" rid="R69">69</xref></sup> was used to allow deformations in the <italic>xy</italic> plane independent from the <italic>z</italic> -axis. During these equilibration steps, harmonic restraints on the positions of the lipid and protein atoms were gradually switched off. Equations of motion were integrated with a standard leap-frog algorithm with a timestep of 1fs or 2fs, depending on the stage of equilibration.</p></sec><sec id="S17"><title>Production</title><p id="P46">MD and bAIes structural refinement production simulations were run for 5ns post-equilibration. For soluble proteins, simulations were performed in the NVT ensemble with a timestep of 1fs. Temperature was set at 300K using the Bussi-Donadio-Parrinello thermostat with time constant of 0.2ps. For membrane proteins, simulations were performed in the NPT ensemble with a timestep of 2fs. Temperature was set at 303.15K using the Bussi-Donadio-Parrinello as for soluble proteins; pressure was set at 1bar using the semi-isotropic Parrinello-Rahman barostat<sup><xref ref-type="bibr" rid="R74">74</xref></sup> with time constant of 5ps. For bAIes simulations, restraints were applied with frequency equal to 4fs.</p></sec><sec id="S18"><title>Analysis</title><p id="P47">To select representative models from the MD and bAIes trajectories, all generated conformations were clustered according to their binding pocket structure as follows. First, we defined the pocket as the set of protein heavy atoms within 6Å of any heavy atom of the ligand in the X-ray structure. Then we employed the <italic>gromos</italic> clustering approach<sup><xref ref-type="bibr" rid="R75">75</xref></sup> using the RMSD calculated on the <italic>C</italic><sub><italic>β</italic></sub> pocket atoms as metrics. Several clustering cutoffs were tested ranging from 0.01 to 0.13nm. A system-specific cutoff was chosen to ensure a balance between having clusters that were conformationally homogeneous within and distinct from each other.</p></sec></sec><sec id="S19"><title>Benchmark of structural accuracy of ligand binding pockets</title><sec id="S20"><title>Details of the systems</title><p id="P48">15 systems were chosen to benchmark the accuracy of different methods to refine the target structure. The <italic>holo</italic> conformations of these systems were determined by X-ray crystallography at resolution ranging from 1.5Å to 3.2Å (<xref ref-type="supplementary-material" rid="SD1">Table S1</xref>). The systems included a mixture of soluble and membrane proteins. The soluble proteins were: dihydroorotate dehydrogenase (PDB 1D3G), androgen receptor (PDB 2AM9), phosphodiesterase 5A (PDB 1UDT), urokinase-type plasminogen activator (PDB 1SQT), fatty-acid-binding protein 4 (PDB 2NNQ), leukocyte-function associated antigen 1 (PDB 2ICA), heat shock protein 90 <italic>α</italic> (PDB 1UYG), progesterone receptor (PDB 3KBA), purine nucleoside phosphorylase (PDB 3BGS), renin (PDB 3G6Z), thymidine kinase (PDB 2UZ3), hexokinase type IV (PDB 3F9M) and estrogen receptor <italic>α</italic> (PDB 3ERD). The membrane proteins were: <italic>β</italic><sub>2</sub> adrenergic receptor (PDB 4LDO) and dopamine <italic>D</italic><sub>3</sub> receptor (PDB 3PBL). Each target structure was resolved in complex with a native ligand (<xref ref-type="supplementary-material" rid="SD1">Table S1</xref>). Among these systems, 10 were monomers (PDBs 1D3G, 2AM9, 1UDT, 1SQT, 2NNQ, 2ICA, 1UYG, and 4LDO), 3 were homodimers (PDBs 3KBA, 3G6Z, and 3PBL), 1 was a homotetramer (PDB 2UZ3), and 1 was a heterodimer (PDB 3ERD).</p></sec><sec id="S21"><title>Analysis</title><p id="P49">In order to compare the different methods (AF, MD, and bAIes) used in this work, each protein model was first aligned to the corresponding experimental structure. Due to possible missing residues in the experimental structure, we first performed a sequence alignment to the model sequence using Biopython.<sup><xref ref-type="bibr" rid="R76">76</xref></sup> We then used the sequence alignment to perform structural alignment of the AF model, and every frame of the MD and bAIes trajectories, to the reference experimental structure using MDAnalysis v2.7.0.<sup><xref ref-type="bibr" rid="R77">77</xref>,<xref ref-type="bibr" rid="R78">78</xref></sup> The structural alignments and RMSD calculations were performed on the <italic>C</italic><sub><italic>β</italic></sub> atoms of the pocket residues, as previously described for the clustering of MD and bAIes trajectories.</p></sec></sec><sec id="S22"><title>Benchmark of structural accuracy of native ligand docking poses</title><sec id="S23"><title>Details of the systems</title><p id="P50">The same 15 systems defined in the previous section were used to benchmark the accuracy of native ligand docking.</p></sec><sec id="S24"><title>Details of the docking protocol</title><p id="P51">Models produced by the different methods (AF, MD and bAIes) were first stripped of any lipids, ions and water molecules present, and empirical atomic partial charges in the form of Gasteiger charges were added. The experimental structures were prepared for docking by removing the native ligands present in it. Autodock Vina 1.1.2<sup><xref ref-type="bibr" rid="R79">79</xref>,<xref ref-type="bibr" rid="R80">80</xref></sup> was used to dock each ligand to its receptor. A moderate exhaustiveness of 8 was used to specify the number of independent runs starting from random ligand conformations for each docking trial. This value is typically considered a good trade-off between computational cost and accuracies in Autodock Vina. <sup><xref ref-type="bibr" rid="R81">81</xref></sup> A cubic box centered at the centre of mass of the experimental native ligand structure and with side equal to 20Å was used for docking. The default united-atom scoring function was used to rank the docked ligands. <sup><xref ref-type="bibr" rid="R79">79</xref></sup></p></sec><sec id="S25"><title>Analysis</title><p id="P52">For each docked ligand, the ligand RMSD (RMSD<sub><italic>l</italic></sub>) with respect to the experimental structure was calculated. In the case of MD and bAIes, the poses obtained by docking the ligand to the three most populated clusters were combined, and the 5 top scoring poses were considered. Out of these 5 poses, the one with lowest RMSD<sub><italic>l</italic></sub> was selected. A docking trial was considered successful if RMSD<sub><italic>l</italic></sub> &lt; 2Å.</p></sec></sec><sec id="S26"><title>Virtual screening of small molecule libraries</title><sec id="S27"><title>Details of the systems</title><p id="P53">The following 3 systems were chosen for benchmarking the virtual screening of large libraries of small molecules against the AF, MD and bAIes models: the estrogen receptor <italic>α</italic> (PDB 3ERD), the purine nucleoside phosphorylase (PDB 3BGS), and the cyclin-dependent kinase (PDB 1H00). The structure of these systems were determined by X-ray crystallography at high resolution (PDB 3ERD: 2.0Å; PDB 3BGS: 2.1Å; PDB 1H00: 1.6Å). Two of these systems were monomers (PDB 3BGS and 1H00) and one was a heterodimer (PDB 3ERD).</p></sec><sec id="S28"><title>Details of the small molecule libraries</title><p id="P54">For the estrogen receptor <italic>α</italic>, a library of 391 actives and 21642 decoys was downloaded from the DUD-E database.<sup><xref ref-type="bibr" rid="R82">82</xref></sup> For the purine nucleoside phosphorylase, a library of 233 actives and 7016 decoys was downloaded from NRLiSt BDB.<sup><xref ref-type="bibr" rid="R83">83</xref></sup> For the cyclin-dependent kinase, a library of 798 actives and 28329 decoys was downloaded from the DUD-E database.</p></sec><sec id="S29"><title>Details of the virtual screening protocol</title><p id="P55">For each system of our benchmark, the AF model, the most populated MD and bAIes clusters, and the experimental structure were prepared for virtual screening using the same protocol defined for native ligand docking.</p></sec><sec id="S30"><title>Analysis</title><p id="P56">To analyze the output of our virtual screening, only the top scoring pose of each small molecule was considered. The docking performance of each method was then evaluated independently for each system in the benchmark set in the following way. First, we sorted the small molecules by their docking scores, then we computed the ROC curve by counting the number of true and false positives as the docking score threshold to select molecules was varied. We measured early enrichment quality of the receptors with the pROC curve, for which we used a log<sub>10</sub> scale for the false positives (<xref ref-type="fig" rid="F4">Fig. 4b</xref>).</p></sec></sec></sec><sec sec-type="supplementary-material" id="SM"><title>Supplementary Material</title><supplementary-material content-type="local-data" id="SD1"><label>Supplementary Information</label><media xlink:href="EMS207036-supplement-Supplementary_Information.pdf" mimetype="application" mime-subtype="pdf" id="d50aAcFbB" position="anchor"/></supplementary-material></sec></body><back><ack id="S31"><title>Acknowledgments</title><p>We thank Quang Tru Huynh for technical support with the Maestro cluster at Institut Pasteur. This project has received funding from the European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation programme (Grant agreement No. 101086685 – bAIes).</p></ack><sec id="S32" sec-type="data-availability"><title>Software and data availability</title><p id="P57">bAIes is implemented as a part of the PLUMED-ISDB module<sup><xref ref-type="bibr" rid="R57">57</xref></sup> in the development version (GitHub master branch) of PLUMED (<ext-link ext-link-type="uri" xlink:href="https://github.com/plumed/plumed2">https://github.com/plumed/plumed2</ext-link>).<sup><xref ref-type="bibr" rid="R48">48</xref></sup> The GROMACS topologies and PLUMED input files used in our benchmarks are available in PLUMED-NEST (<ext-link ext-link-type="uri" xlink:href="http://www.plumed-nest.org">www.plumed-nest.org</ext-link>), the public repository of the PLUMED consortium,<sup><xref ref-type="bibr" rid="R49">49</xref></sup> as plumID:25.016.</p></sec><ref-list><ref id="R1"><label>(1)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>DiMasi</surname><given-names>JA</given-names></name><name><surname>Hansen</surname><given-names>RW</given-names></name><name><surname>Grabowski</surname><given-names>HG</given-names></name></person-group><article-title>The price of innovation: new estimates of drug development costs</article-title><source>Journal of Health Economics</source><year>2003</year><volume>22</volume><fpage>151</fpage><lpage>185</lpage><pub-id pub-id-type="pmid">12606142</pub-id></element-citation></ref><ref id="R2"><label>(2)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Villoutreix</surname><given-names>BO</given-names></name><name><surname>Eudes</surname><given-names>R</given-names></name><name><surname>Miteva</surname><given-names>MA</given-names></name></person-group><article-title>Structure-based virtual ligand screening: recent success stories</article-title><source>Combinatorial chemistry &amp; high throughput screening</source><year>2009</year><volume>12</volume><fpage>1000</fpage><lpage>1016</lpage><pub-id pub-id-type="pmid">20025565</pub-id></element-citation></ref><ref id="R3"><label>(3)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Irwin</surname><given-names>JJ</given-names></name><name><surname>Shoichet</surname><given-names>BK</given-names></name><name><surname>Mysinger</surname><given-names>MM</given-names></name><name><surname>Huang</surname><given-names>N</given-names></name><name><surname>Colizzi</surname><given-names>F</given-names></name><name><surname>Wassam</surname><given-names>P</given-names></name><name><surname>Cao</surname><given-names>Y</given-names></name></person-group><article-title>Automated Docking Screens: A Feasibility Study</article-title><source>Journal of Medicinal Chemistry</source><year>2009</year><volume>52</volume><fpage>5712</fpage><lpage>5720</lpage><pub-id pub-id-type="doi">10.1021/jm9006966</pub-id><pub-id pub-id-type="pmcid">PMC2745826</pub-id><pub-id pub-id-type="pmid">19719084</pub-id></element-citation></ref><ref id="R4"><label>(4)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lavecchia A</surname><given-names>DGC</given-names></name></person-group><article-title>Virtual Screening Strategies in Drug Discovery: A Critical Review</article-title><source>Current Medicinal Chemistry</source><year>2013</year><volume>20</volume><fpage>2839</fpage><lpage>2860</lpage><pub-id pub-id-type="pmid">23651302</pub-id></element-citation></ref><ref id="R5"><label>(5)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walters</surname><given-names>W</given-names></name><name><surname>Stahl</surname><given-names>MT</given-names></name><name><surname>Murcko</surname><given-names>MA</given-names></name></person-group><article-title>Virtual screening—an overview</article-title><source>Drug Discovery Today</source><year>1998</year><volume>3</volume><fpage>160</fpage><lpage>178</lpage></element-citation></ref><ref id="R6"><label>(6)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shoichet</surname><given-names>BK</given-names></name></person-group><article-title>Virtual screening of chemical libraries</article-title><source>Nature</source><year>2004</year><volume>432</volume><fpage>862</fpage><lpage>865</lpage><pub-id pub-id-type="doi">10.1038/nature03197</pub-id><pub-id pub-id-type="pmcid">PMC1360234</pub-id><pub-id pub-id-type="pmid">15602552</pub-id></element-citation></ref><ref id="R7"><label>(7)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beddell</surname><given-names>C</given-names></name><name><surname>Goodford</surname><given-names>P</given-names></name><name><surname>Norrington</surname><given-names>F</given-names></name><name><surname>Wilkinson</surname><given-names>S</given-names></name><name><surname>Wootton</surname><given-names>R</given-names></name></person-group><article-title>Compounds designed to fit a site of known structure in human haemoglobin</article-title><source>British journal of pharmacology</source><year>1976</year><volume>57</volume><fpage>201</fpage><lpage>209</lpage><pub-id pub-id-type="doi">10.1111/j.1476-5381.1976.tb07468.x</pub-id><pub-id pub-id-type="pmcid">PMC1667110</pub-id><pub-id pub-id-type="pmid">938794</pub-id></element-citation></ref><ref id="R8"><label>(8)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tuccinardi</surname><given-names>T</given-names></name></person-group><article-title>Docking-based virtual screening: recent developments</article-title><source>Combinatorial chemistry &amp; high throughput screening</source><year>2009</year><volume>12</volume><fpage>303</fpage><lpage>314</lpage><pub-id pub-id-type="pmid">19275536</pub-id></element-citation></ref><ref id="R9"><label>(9)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brooijmans</surname><given-names>N</given-names></name><name><surname>Kuntz</surname><given-names>ID</given-names></name></person-group><article-title>Molecular recognition and docking algorithms</article-title><source>Annual review of biophysics and biomolecular structure</source><year>2003</year><volume>32</volume><fpage>335</fpage><lpage>373</lpage><pub-id pub-id-type="pmid">12574069</pub-id></element-citation></ref><ref id="R10"><label>(10)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Halperin</surname><given-names>I</given-names></name><name><surname>Ma</surname><given-names>B</given-names></name><name><surname>Wolfson</surname><given-names>H</given-names></name><name><surname>Nussinov</surname><given-names>R</given-names></name></person-group><article-title>Principles of docking: An overview of search algorithms and a guide to scoring functions</article-title><source>Proteins: Structure, Function, and Bioinformatics</source><year>2002</year><volume>47</volume><fpage>409</fpage><lpage>443</lpage><pub-id pub-id-type="pmid">12001221</pub-id></element-citation></ref><ref id="R11"><label>(11)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bordogna</surname><given-names>A</given-names></name><name><surname>Pandini</surname><given-names>A</given-names></name><name><surname>Bonati</surname><given-names>L</given-names></name></person-group><article-title>Predicting the accuracy of protein–ligand docking on homology models</article-title><source>Journal of computational chemistry</source><year>2011</year><volume>32</volume><fpage>81</fpage><lpage>98</lpage><pub-id pub-id-type="doi">10.1002/jcc.21601</pub-id><pub-id pub-id-type="pmcid">PMC3057020</pub-id><pub-id pub-id-type="pmid">20607693</pub-id></element-citation></ref><ref id="R12"><label>(12)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cavasotto</surname><given-names>CN</given-names></name><name><surname>Phatak</surname><given-names>SS</given-names></name></person-group><article-title>Homology modeling in drug discovery: current trends and applications</article-title><source>Drug discovery today</source><year>2009</year><volume>14</volume><fpage>676</fpage><lpage>683</lpage><pub-id pub-id-type="pmid">19422931</pub-id></element-citation></ref><ref id="R13"><label>(13)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holcomb</surname><given-names>M</given-names></name><name><surname>Chang</surname><given-names>YT</given-names></name><name><surname>Goodsell</surname><given-names>DS</given-names></name><name><surname>Forli</surname><given-names>S</given-names></name></person-group><article-title>Evaluation of AlphaFold2 structures as docking targets</article-title><source>Protein Science</source><year>2023</year><volume>32</volume><elocation-id>e4530</elocation-id><pub-id pub-id-type="doi">10.1002/pro.4530</pub-id><pub-id pub-id-type="pmcid">PMC9794023</pub-id><pub-id pub-id-type="pmid">36479776</pub-id></element-citation></ref><ref id="R14"><label>(14)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jumper</surname><given-names>J</given-names></name><name><surname>Evans</surname><given-names>R</given-names></name><name><surname>Pritzel</surname><given-names>A</given-names></name><name><surname>Green</surname><given-names>T</given-names></name><name><surname>Figurnov</surname><given-names>M</given-names></name><name><surname>Ronneberger</surname><given-names>O</given-names></name><name><surname>Tunyasuvunakool</surname><given-names>K</given-names></name><name><surname>Bates</surname><given-names>R</given-names></name><name><surname>Zídek</surname><given-names>A</given-names></name><name><surname>Potapenko</surname><given-names>A</given-names></name><collab>others</collab></person-group><article-title>Highly accurate protein structure prediction with AlphaFold</article-title><source>Nature</source><year>2021</year><volume>596</volume><fpage>583</fpage><lpage>589</lpage><pub-id pub-id-type="doi">10.1038/s41586-021-03819-2</pub-id><pub-id pub-id-type="pmcid">PMC8371605</pub-id><pub-id pub-id-type="pmid">34265844</pub-id></element-citation></ref><ref id="R15"><label>(15)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hameduh</surname><given-names>T</given-names></name><name><surname>Haddad</surname><given-names>Y</given-names></name><name><surname>Adam</surname><given-names>V</given-names></name><name><surname>Heger</surname><given-names>Z</given-names></name></person-group><article-title>Homology modeling in the time of collective and artificial intelligence</article-title><source>Computational and Structural Biotechnology Journal</source><year>2020</year><volume>18</volume><fpage>3494</fpage><lpage>3506</lpage><pub-id pub-id-type="doi">10.1016/j.csbj.2020.11.007</pub-id><pub-id pub-id-type="pmcid">PMC7695898</pub-id><pub-id pub-id-type="pmid">33304450</pub-id></element-citation></ref><ref id="R16"><label>(16)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tunyasuvunakool</surname><given-names>K</given-names></name><etal/></person-group><article-title>Highly accurate protein structure prediction for the human proteome</article-title><source>Nature</source><year>2021</year><volume>596</volume><fpage>590</fpage><lpage>596</lpage><pub-id pub-id-type="doi">10.1038/s41586-021-03828-1</pub-id><pub-id pub-id-type="pmcid">PMC8387240</pub-id><pub-id pub-id-type="pmid">34293799</pub-id></element-citation></ref><ref id="R17"><label>(17)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Porta-Pardo</surname><given-names>E</given-names></name><name><surname>Ruiz-Serra</surname><given-names>V</given-names></name><name><surname>Valentini</surname><given-names>S</given-names></name><name><surname>Valencia</surname><given-names>A</given-names></name></person-group><article-title>The structural coverage of the human proteome before and after AlphaFold</article-title><source>PLOS Computational Biology</source><year>2022</year><volume>18</volume><fpage>1</fpage><lpage>17</lpage><pub-id pub-id-type="doi">10.1371/journal.pcbi.1009818</pub-id><pub-id pub-id-type="pmcid">PMC8812986</pub-id><pub-id pub-id-type="pmid">35073311</pub-id></element-citation></ref><ref id="R18"><label>(18)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scardino</surname><given-names>V</given-names></name><name><surname>Di Filippo</surname><given-names>JI</given-names></name><name><surname>Cavasotto</surname><given-names>CN</given-names></name></person-group><article-title>How good are AlphaFold models for docking-based virtual screening?</article-title><source>iScience</source><year>2023</year><volume>26</volume><elocation-id>105920</elocation-id><pub-id pub-id-type="doi">10.1016/j.isci.2022.105920</pub-id><pub-id pub-id-type="pmcid">PMC9852548</pub-id><pub-id pub-id-type="pmid">36686396</pub-id></element-citation></ref><ref id="R19"><label>(19)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Vass</surname><given-names>M</given-names></name><name><surname>Shi</surname><given-names>D</given-names></name><name><surname>Abualrous</surname><given-names>E</given-names></name><name><surname>Chambers</surname><given-names>JM</given-names></name><name><surname>Chopra</surname><given-names>N</given-names></name><name><surname>Higgs</surname><given-names>C</given-names></name><name><surname>Kasavajhala</surname><given-names>K</given-names></name><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Nandekar</surname><given-names>P</given-names></name><name><surname>Sato</surname><given-names>H</given-names></name><etal/></person-group><article-title>Benchmarking Refined and Unrefined AlphaFold2 Structures for Hit Discovery</article-title><source>Journal of Chemical Information and Modeling</source><year>2023</year><volume>63</volume><fpage>1656</fpage><lpage>1667</lpage><pub-id pub-id-type="pmid">36897766</pub-id></element-citation></ref><ref id="R20"><label>(20)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lyu</surname><given-names>J</given-names></name><etal/></person-group><article-title>AlphaFold2 structures guide prospective ligand discovery</article-title><source>Science</source><year>2024</year><volume>384</volume><elocation-id>eadn6354</elocation-id><pub-id pub-id-type="doi">10.1126/science.adn6354</pub-id><pub-id pub-id-type="pmcid">PMC11253030</pub-id><pub-id pub-id-type="pmid">38753765</pub-id></element-citation></ref><ref id="R21"><label>(21)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kersten</surname><given-names>C</given-names></name><name><surname>Clower</surname><given-names>S</given-names></name><name><surname>Barthels</surname><given-names>F</given-names></name></person-group><article-title>Hic Sunt Dracones: Molecular Docking in Uncharted Territories with Structures from AlphaFold2 and RoseTTAfold</article-title><source>Journal of Chemical Information and Modeling</source><year>2023</year><volume>63</volume><fpage>2218</fpage><lpage>2225</lpage><pub-id pub-id-type="pmid">36884022</pub-id></element-citation></ref><ref id="R22"><label>(22)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ruff</surname><given-names>KM</given-names></name><name><surname>Pappu</surname><given-names>RV</given-names></name></person-group><article-title>AlphaFold and Implications for Intrinsically Disordered Proteins</article-title><source>Journal of Molecular Biology</source><year>2021</year><volume>433</volume><elocation-id>167208</elocation-id><pub-id pub-id-type="pmid">34418423</pub-id></element-citation></ref><ref id="R23"><label>(23)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martí-Renom</surname><given-names>MA</given-names></name><name><surname>Stuart</surname><given-names>AC</given-names></name><name><surname>Fiser</surname><given-names>A</given-names></name><name><surname>Sánchez</surname><given-names>R</given-names></name><name><surname>Melo</surname><given-names>F</given-names></name><name><surname>Sali</surname><given-names>A</given-names></name></person-group><article-title>Comparative Protein Structure Modeling of Genes and Genomes</article-title><source>Annual Review of Biophysics</source><year>2000</year><volume>29</volume><fpage>291</fpage><lpage>325</lpage><pub-id pub-id-type="pmid">10940251</pub-id></element-citation></ref><ref id="R24"><label>(24)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meiler</surname><given-names>J</given-names></name><name><surname>Baker</surname><given-names>D</given-names></name></person-group><article-title>ROSETTALIGAND: Protein–small molecule docking with full side-chain flexibility</article-title><source>Proteins: Structure, Function, and Bioinformatics</source><year>2006</year><volume>65</volume><fpage>538</fpage><lpage>548</lpage><pub-id pub-id-type="pmid">16972285</pub-id></element-citation></ref><ref id="R25"><label>(25)</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Dhanik</surname><given-names>A</given-names></name><name><surname>Kavraki</surname><given-names>LE</given-names></name></person-group><source>eLS</source><publisher-name>John Wiley &amp; Sons, Ltd</publisher-name><year>2012</year></element-citation></ref><ref id="R26"><label>(26)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feig</surname><given-names>M</given-names></name></person-group><article-title>Local Protein Structure Refinement via Molecular Dynamics Simulations with locPREFMD</article-title><source>Journal of Chemical Information and Modeling</source><year>2016</year><volume>56</volume><fpage>1304</fpage><lpage>1312</lpage><pub-id pub-id-type="doi">10.1021/acs.jcim.6b00222</pub-id><pub-id pub-id-type="pmcid">PMC4962792</pub-id><pub-id pub-id-type="pmid">27380201</pub-id></element-citation></ref><ref id="R27"><label>(27)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname><given-names>EB</given-names></name><etal/></person-group><article-title>Reliable and Accurate Solution to the Induced Fit Docking Problem for Protein–Ligand Binding</article-title><source>Journal of Chemical Theory and Computation</source><year>2021</year><volume>17</volume><fpage>2630</fpage><lpage>2639</lpage><pub-id pub-id-type="pmid">33779166</pub-id></element-citation></ref><ref id="R28"><label>(28)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Koirala</surname><given-names>K</given-names></name><name><surname>Do</surname><given-names>HN</given-names></name><name><surname>Miao</surname><given-names>Y</given-names></name></person-group><article-title>PepBinding: A Workflow for Predicting Peptide Binding Structures by Combining Peptide Docking and Peptide Gaussian Accelerated Molecular Dynamics Simulations</article-title><source>The Journal of Physical Chemistry B</source><year>2024</year><volume>128</volume><fpage>7332</fpage><lpage>7340</lpage><pub-id pub-id-type="pmid">39041172</pub-id></element-citation></ref><ref id="R29"><label>(29)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chipot</surname><given-names>C</given-names></name></person-group><article-title>Recent Advances in Simulation Software and Force Fields: Their Importance in Theoretical and Computational Chemistry and Biophysics</article-title><source>The Journal of Physical Chemistry B</source><year>2024</year><volume>128</volume><fpage>12023</fpage><lpage>12026</lpage><pub-id pub-id-type="pmid">39663898</pub-id></element-citation></ref><ref id="R30"><label>(30)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhattacharya</surname><given-names>D</given-names></name><name><surname>Cheng</surname><given-names>J</given-names></name></person-group><article-title>3Drefine: Consistent protein structure refinement by optimizing hydrogen bonding network and atomic-level energy minimization</article-title><source>Proteins: Structure, Function, and Bioinformatics</source><year>2013</year><volume>81</volume><fpage>119</fpage><lpage>131</lpage><pub-id pub-id-type="doi">10.1002/prot.24167</pub-id><pub-id pub-id-type="pmcid">PMC3634918</pub-id><pub-id pub-id-type="pmid">22927229</pub-id></element-citation></ref><ref id="R31"><label>(31)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heo</surname><given-names>L</given-names></name><name><surname>Feig</surname><given-names>M</given-names></name></person-group><article-title>What makes it difficult to refine protein models further via molecular dynamics simulations?</article-title><source>Proteins: Structure, Function, and Bioinformatics</source><year>2018</year><volume>86</volume><fpage>177</fpage><lpage>188</lpage><pub-id pub-id-type="doi">10.1002/prot.25393</pub-id><pub-id pub-id-type="pmcid">PMC5820117</pub-id><pub-id pub-id-type="pmid">28975670</pub-id></element-citation></ref><ref id="R32"><label>(32)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heo</surname><given-names>L</given-names></name><name><surname>Janson</surname><given-names>G</given-names></name><name><surname>Feig</surname><given-names>M</given-names></name></person-group><article-title>Physics-based protein structure refinement in the era of artificial intelligence</article-title><source>Proteins: Structure, Function, and Bioinformatics</source><year>2021</year><volume>89</volume><fpage>1870</fpage><lpage>1887</lpage><pub-id pub-id-type="doi">10.1002/prot.26161</pub-id><pub-id pub-id-type="pmcid">PMC8616793</pub-id><pub-id pub-id-type="pmid">34156124</pub-id></element-citation></ref><ref id="R33"><label>(33)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feig</surname><given-names>M</given-names></name><name><surname>Mirjalili</surname><given-names>V</given-names></name></person-group><article-title>Protein structure refinement via molecular-dynamics simulations: what works and what does not?</article-title><source>Proteins: Structure, Function, and Bioinformatics</source><year>2016</year><volume>84</volume><fpage>282</fpage><lpage>292</lpage><pub-id pub-id-type="doi">10.1002/prot.24871</pub-id><pub-id pub-id-type="pmcid">PMC5493977</pub-id><pub-id pub-id-type="pmid">26234208</pub-id></element-citation></ref><ref id="R34"><label>(34)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feig</surname><given-names>M</given-names></name></person-group><article-title>Computational protein structure refinement: almost there, yet still so far to go</article-title><source>Wiley Interdisciplinary Reviews: Computational Molecular Science</source><year>2017</year><volume>7</volume><elocation-id>e1307</elocation-id><pub-id pub-id-type="doi">10.1002/wcms.1307</pub-id><pub-id pub-id-type="pmcid">PMC6319934</pub-id><pub-id pub-id-type="pmid">30613211</pub-id></element-citation></ref><ref id="R35"><label>(35)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heller</surname><given-names>GT</given-names></name><etal/></person-group><article-title>Small-molecule sequestration of amyloid-<italic>β</italic> as a drug discovery strategy for Alzheimer’s disease</article-title><source>Science Advances</source><year>2020</year><volume>6</volume><elocation-id>eabb5924</elocation-id><pub-id pub-id-type="doi">10.1126/sciadv.abb5924</pub-id><pub-id pub-id-type="pmcid">PMC7673680</pub-id><pub-id pub-id-type="pmid">33148639</pub-id></element-citation></ref><ref id="R36"><label>(36)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jussupow</surname><given-names>A</given-names></name><name><surname>Messias</surname><given-names>AC</given-names></name><name><surname>Stehle</surname><given-names>R</given-names></name><name><surname>Geerlof</surname><given-names>A</given-names></name><name><surname>Solbak</surname><given-names>SM</given-names></name><name><surname>Paissoni</surname><given-names>C</given-names></name><name><surname>Bach</surname><given-names>A</given-names></name><name><surname>Sattler</surname><given-names>M</given-names></name><name><surname>Camilloni</surname><given-names>C</given-names></name></person-group><article-title>The dynamics of linear polyubiquitin</article-title><source>Science Advances</source><year>2020</year><volume>6</volume><elocation-id>eabc3786</elocation-id><pub-id pub-id-type="doi">10.1126/sciadv.abc3786</pub-id><pub-id pub-id-type="pmcid">PMC7556843</pub-id><pub-id pub-id-type="pmid">33055165</pub-id></element-citation></ref><ref id="R37"><label>(37)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoff</surname><given-names>SE</given-names></name><name><surname>Thomasen</surname><given-names>FE</given-names></name><name><surname>Lindorff-Larsen</surname><given-names>K</given-names></name><name><surname>Bonomi</surname><given-names>M</given-names></name></person-group><article-title>Accurate model and ensemble refinement using cryo-electron microscopy maps and Bayesian inference</article-title><source>PLOS Computational Biology</source><year>2024</year><volume>20</volume><fpage>1</fpage><lpage>26</lpage><pub-id pub-id-type="doi">10.1371/journal.pcbi.1012180</pub-id><pub-id pub-id-type="pmcid">PMC11271924</pub-id><pub-id pub-id-type="pmid">39008528</pub-id></element-citation></ref><ref id="R38"><label>(38)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kamisetty</surname><given-names>H</given-names></name><name><surname>Ovchinnikov</surname><given-names>S</given-names></name><name><surname>Baker</surname><given-names>D</given-names></name></person-group><article-title>Assessing the utility of coevolution-based residue–residue contact predictions in a sequence- and structure-rich era</article-title><source>Proceedings of the National Academy of Sciences</source><year>2013</year><volume>110</volume><fpage>15674</fpage><lpage>15679</lpage><pub-id pub-id-type="doi">10.1073/pnas.1314045110</pub-id><pub-id pub-id-type="pmcid">PMC3785744</pub-id><pub-id pub-id-type="pmid">24009338</pub-id></element-citation></ref><ref id="R39"><label>(39)</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Sivia</surname><given-names>D</given-names></name><name><surname>Skilling</surname><given-names>J</given-names></name></person-group><source>Data Analysis: A Bayesian Tutorial</source><publisher-name>Oxford University Press</publisher-name><publisher-loc>Oxford</publisher-loc><year>2006</year><edition>2nd</edition></element-citation></ref><ref id="R40"><label>(40)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karelina</surname><given-names>M</given-names></name><name><surname>Noh</surname><given-names>JJ</given-names></name><name><surname>Dror</surname><given-names>RO</given-names></name></person-group><article-title>How accurately can one predict drug binding modes using AlphaFold models?</article-title><source>eLife</source><year>2023</year><volume>12</volume><elocation-id>RP89386</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.89386</pub-id><pub-id pub-id-type="pmcid">PMC10746139</pub-id><pub-id pub-id-type="pmid">38131311</pub-id></element-citation></ref><ref id="R41"><label>(41)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gohlke</surname><given-names>H</given-names></name><name><surname>Hendlich</surname><given-names>M</given-names></name><name><surname>Klebe</surname><given-names>G</given-names></name></person-group><article-title>Knowledge-based scoring function to predict protein-ligand interactions11Edited by R. Huber</article-title><source>Journal of Molecular Biology</source><year>2000</year><volume>295</volume><fpage>337</fpage><lpage>356</lpage><pub-id pub-id-type="pmid">10623530</pub-id></element-citation></ref><ref id="R42"><label>(42)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guterres</surname><given-names>H</given-names></name><name><surname>Park</surname><given-names>SJ</given-names></name><name><surname>Jiang</surname><given-names>W</given-names></name><name><surname>Im</surname><given-names>W</given-names></name></person-group><article-title>Ligand-binding-site refinement to generate reliable holo protein structure conformations from apo structures</article-title><source>Journal of chemical information and modeling</source><year>2020</year><volume>61</volume><fpage>535</fpage><lpage>546</lpage><pub-id pub-id-type="doi">10.1021/acs.jcim.0c01354</pub-id><pub-id pub-id-type="pmcid">PMC7856192</pub-id><pub-id pub-id-type="pmid">33337877</pub-id></element-citation></ref><ref id="R43"><label>(43)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zweig</surname><given-names>MH</given-names></name><name><surname>Campbell</surname><given-names>G</given-names></name></person-group><article-title>Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine</article-title><source>Clinical chemistry</source><year>1993</year><volume>39</volume><fpage>561</fpage><lpage>577</lpage><pub-id pub-id-type="pmid">8472349</pub-id></element-citation></ref><ref id="R44"><label>(44)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Knight</surname><given-names>IS</given-names></name><name><surname>Naprienko</surname><given-names>S</given-names></name><name><surname>Irwin</surname><given-names>JJ</given-names></name></person-group><article-title>Enrichment Score: a better quantitative metric for evaluating the enrichment capacity of molecular docking models</article-title><source>arXiv</source><year>2023</year><elocation-id>2210.10905</elocation-id></element-citation></ref><ref id="R45"><label>(45)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wei</surname><given-names>BQ</given-names></name><name><surname>Baase</surname><given-names>WA</given-names></name><name><surname>Weaver</surname><given-names>LH</given-names></name><name><surname>Matthews</surname><given-names>BW</given-names></name><name><surname>Shoichet</surname><given-names>BK</given-names></name></person-group><article-title>A Model Binding Site for Testing Scoring Functions in Molecular Docking</article-title><source>Journal of Molecular Biology</source><year>2002</year><volume>322</volume><fpage>339</fpage><lpage>355</lpage><pub-id pub-id-type="pmid">12217695</pub-id></element-citation></ref><ref id="R46"><label>(46)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>W</given-names></name><name><surname>Hevener</surname><given-names>K</given-names></name><name><surname>White</surname><given-names>S</given-names></name><name><surname>Lee</surname><given-names>R</given-names></name><name><surname>Boyett</surname><given-names>J</given-names></name></person-group><article-title>A statistical framework to evaluate virtual screening</article-title><source>BMC bioinformatics</source><year>2009</year><volume>10</volume><fpage>225</fpage><pub-id pub-id-type="doi">10.1186/1471-2105-10-225</pub-id><pub-id pub-id-type="pmcid">PMC2722655</pub-id><pub-id pub-id-type="pmid">19619306</pub-id></element-citation></ref><ref id="R47"><label>(47)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schnapka</surname><given-names>V</given-names></name><name><surname>Morozova</surname><given-names>T</given-names></name><name><surname>Sen</surname><given-names>S</given-names></name><name><surname>Bonomi</surname><given-names>M</given-names></name></person-group><article-title>Atomic resolution ensembles of intrinsically disordered and multi-domain proteins with Alphafold</article-title><source>bioRxiv</source><year>2025</year><pub-id pub-id-type="doi">10.1101/2025.06.18.660298</pub-id></element-citation></ref><ref id="R48"><label>(48)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tribello</surname><given-names>GA</given-names></name><name><surname>Bonomi</surname><given-names>M</given-names></name><name><surname>Branduardi</surname><given-names>D</given-names></name><name><surname>Camilloni</surname><given-names>C</given-names></name><name><surname>Bussi</surname><given-names>G</given-names></name></person-group><article-title>PLUMED 2: New feathers for an old bird</article-title><source>Computer Physics Communications</source><year>2014</year><volume>185</volume><fpage>604</fpage><lpage>613</lpage></element-citation></ref><ref id="R49"><label>(49)</label><element-citation publication-type="journal"><article-title>PLUMED consortium Promoting transparency and reproducibility in enhanced molecular simulations</article-title><source>Nature Methods</source><year>2019</year><volume>16</volume><fpage>670</fpage><lpage>673</lpage><pub-id pub-id-type="pmid">31363226</pub-id></element-citation></ref><ref id="R50"><label>(50)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sarkar</surname><given-names>A</given-names></name><name><surname>Concilio</surname><given-names>S</given-names></name><name><surname>Sessa</surname><given-names>L</given-names></name><name><surname>Marrafino</surname><given-names>F</given-names></name><name><surname>Piotto</surname><given-names>S</given-names></name></person-group><article-title>Advancements and novel approaches in modified AutoDock Vina algorithms for enhanced molecular docking</article-title><source>Results in Chemistry</source><year>2024</year><volume>7</volume><elocation-id>101319</elocation-id></element-citation></ref><ref id="R51"><label>(51)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>N</given-names></name><name><surname>Chaput</surname><given-names>L</given-names></name><name><surname>Villoutreix</surname><given-names>BO</given-names></name></person-group><article-title>Fast Rescoring Protocols to Improve the Performance of Structure-Based Virtual Screening Performed on Protein–Protein Interfaces</article-title><source>Journal of Chemical Information and Modeling</source><year>2020</year><volume>60</volume><fpage>3910</fpage><lpage>3934</lpage><pub-id pub-id-type="pmid">32786511</pub-id></element-citation></ref><ref id="R52"><label>(52)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Graves</surname><given-names>AP</given-names></name><name><surname>Shivakumar</surname><given-names>DM</given-names></name><name><surname>Boyce</surname><given-names>SE</given-names></name><name><surname>Jacobson</surname><given-names>MP</given-names></name><name><surname>Case</surname><given-names>DA</given-names></name><name><surname>Shoichet</surname><given-names>BK</given-names></name></person-group><article-title>Rescoring docking hit lists for model cavity sites: predictions and experimental testing</article-title><source>Journal of Molecular Biology</source><year>2008</year><volume>377</volume><fpage>914</fpage><lpage>934</lpage><pub-id pub-id-type="doi">10.1016/j.jmb.2008.01.049</pub-id><pub-id pub-id-type="pmcid">PMC2752715</pub-id><pub-id pub-id-type="pmid">18280498</pub-id></element-citation></ref><ref id="R53"><label>(53)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gentile</surname><given-names>F</given-names></name><name><surname>Agrawal</surname><given-names>V</given-names></name><name><surname>Hsing</surname><given-names>M</given-names></name><name><surname>Ton</surname><given-names>AT</given-names></name><name><surname>Ban</surname><given-names>F</given-names></name><name><surname>Norinder</surname><given-names>U</given-names></name><name><surname>Gleave</surname><given-names>ME</given-names></name><name><surname>Cherkasov</surname><given-names>A</given-names></name></person-group><article-title>Deep Docking: A Deep Learning Platform for Augmentation of Structure Based Drug Discovery</article-title><source>ACS Central Science</source><year>2020</year><volume>6</volume><fpage>939</fpage><lpage>949</lpage><pub-id pub-id-type="doi">10.1021/acscentsci.0c00229</pub-id><pub-id pub-id-type="pmcid">PMC7318080</pub-id><pub-id pub-id-type="pmid">32607441</pub-id></element-citation></ref><ref id="R54"><label>(54)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname><given-names>L</given-names></name><name><surname>Meng</surname><given-names>J</given-names></name><name><surname>Jiang</surname><given-names>K</given-names></name><name><surname>Lan</surname><given-names>H</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Lin</surname><given-names>M</given-names></name><name><surname>Li</surname><given-names>W</given-names></name><name><surname>Guo</surname><given-names>H</given-names></name><name><surname>Wei</surname><given-names>Y</given-names></name><name><surname>Mu</surname><given-names>Y</given-names></name></person-group><article-title>Improving protein–ligand docking and screening accuracies by incorporating a scoring function correction term</article-title><source>Briefings in Bioinformatics</source><year>2022</year><volume>23</volume><elocation-id>bbac051</elocation-id><pub-id pub-id-type="doi">10.1093/bib/bbac051</pub-id><pub-id pub-id-type="pmcid">PMC9116214</pub-id><pub-id pub-id-type="pmid">35289359</pub-id></element-citation></ref><ref id="R55"><label>(55)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Panei</surname><given-names>FP</given-names></name><name><surname>Torchet</surname><given-names>R</given-names></name><name><surname>Mènager</surname><given-names>H</given-names></name><name><surname>Gkeka</surname><given-names>P</given-names></name><name><surname>Bonomi</surname><given-names>M</given-names></name></person-group><article-title>HARIBOSS: a curated database of RNA-small molecules structures to aid rational drug design</article-title><source>Bioinformatics</source><year>2022</year><volume>38</volume><fpage>4185</fpage><lpage>4193</lpage><pub-id pub-id-type="pmid">35799352</pub-id></element-citation></ref><ref id="R56"><label>(56)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Panei</surname><given-names>FP</given-names></name><name><surname>Gkeka</surname><given-names>P</given-names></name><name><surname>Bonomi</surname><given-names>M</given-names></name></person-group><article-title>Identifying small-molecules binding sites in RNA conformational ensembles with SHAMAN</article-title><source>Nature Communications</source><year>2024</year><volume>15</volume><elocation-id>5725</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-024-49638-7</pub-id><pub-id pub-id-type="pmcid">PMC11231146</pub-id><pub-id pub-id-type="pmid">38977675</pub-id></element-citation></ref><ref id="R57"><label>(57)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bonomi</surname><given-names>M</given-names></name><name><surname>Camilloni</surname><given-names>C</given-names></name></person-group><article-title>Integrative structural and dynamical biology with PLUMED-ISDB</article-title><source>Bioinformatics</source><year>2017</year><volume>33</volume><fpage>3999</fpage><lpage>4000</lpage><pub-id pub-id-type="pmid">28961689</pub-id></element-citation></ref><ref id="R58"><label>(58)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname><given-names>LS</given-names></name><name><surname>Eddy</surname><given-names>SR</given-names></name><name><surname>Portugaly</surname><given-names>E</given-names></name></person-group><article-title>Hidden Markov model speed heuristic and iterative HMM search procedure</article-title><source>BMC bioinformatics</source><year>2010</year><volume>11</volume><fpage>1</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1186/1471-2105-11-431</pub-id><pub-id pub-id-type="pmcid">PMC2931519</pub-id><pub-id pub-id-type="pmid">20718988</pub-id></element-citation></ref><ref id="R59"><label>(59)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Steinegger</surname><given-names>M</given-names></name><name><surname>Meier</surname><given-names>M</given-names></name><name><surname>Mirdita</surname><given-names>M</given-names></name><name><surname>Vöhringer</surname><given-names>H</given-names></name><name><surname>Haunsberger</surname><given-names>SJ</given-names></name><name><surname>Söding</surname><given-names>J</given-names></name></person-group><article-title>HH-suite3 for fast remote homology detection and deep protein annotation</article-title><source>BMC bioinformatics</source><year>2019</year><volume>20</volume><fpage>1</fpage><lpage>15</lpage><pub-id pub-id-type="doi">10.1186/s12859-019-3019-7</pub-id><pub-id pub-id-type="pmcid">PMC6744700</pub-id><pub-id pub-id-type="pmid">31521110</pub-id></element-citation></ref><ref id="R60"><label>(60)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eddy</surname><given-names>SR</given-names></name></person-group><article-title>Accelerated profile HMM searches</article-title><source>PLoS computational biology</source><year>2011</year><volume>7</volume><elocation-id>e1002195</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pcbi.1002195</pub-id><pub-id pub-id-type="pmcid">PMC3197634</pub-id><pub-id pub-id-type="pmid">22039361</pub-id></element-citation></ref><ref id="R61"><label>(61)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suzek</surname><given-names>BE</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Huang</surname><given-names>H</given-names></name><name><surname>McGarvey</surname><given-names>PB</given-names></name><name><surname>Wu</surname><given-names>CH</given-names></name><name><surname>Consortium</surname><given-names>U</given-names></name></person-group><article-title>UniRef clusters: a comprehensive and scalable alternative for improving sequence similarity searches</article-title><source>Bioinformatics</source><year>2015</year><volume>31</volume><fpage>926</fpage><lpage>932</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btu739</pub-id><pub-id pub-id-type="pmcid">PMC4375400</pub-id><pub-id pub-id-type="pmid">25398609</pub-id></element-citation></ref><ref id="R62"><label>(62)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mitchell</surname><given-names>AL</given-names></name><name><surname>Almeida</surname><given-names>A</given-names></name><name><surname>Beracochea</surname><given-names>M</given-names></name><name><surname>Boland</surname><given-names>M</given-names></name><name><surname>Burgin</surname><given-names>J</given-names></name><name><surname>Cochrane</surname><given-names>G</given-names></name><name><surname>Crusoe</surname><given-names>MR</given-names></name><name><surname>Kale</surname><given-names>V</given-names></name><name><surname>Potter</surname><given-names>SC</given-names></name><name><surname>Richardson</surname><given-names>LJ</given-names></name><collab>others</collab></person-group><article-title>MGnify: the microbiome analysis resource in 2020</article-title><source>Nucleic acids research</source><year>2020</year><volume>48</volume><fpage>D570</fpage><lpage>D578</lpage><pub-id pub-id-type="doi">10.1093/nar/gkz1035</pub-id><pub-id pub-id-type="pmcid">PMC7145632</pub-id><pub-id pub-id-type="pmid">31696235</pub-id></element-citation></ref><ref id="R63"><label>(63)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hornak</surname><given-names>V</given-names></name><name><surname>Abel</surname><given-names>R</given-names></name><name><surname>Okur</surname><given-names>A</given-names></name><name><surname>Strockbine</surname><given-names>B</given-names></name><name><surname>Roitberg</surname><given-names>A</given-names></name><name><surname>Simmerling</surname><given-names>C</given-names></name></person-group><article-title>Comparison of multiple Amber force fields and development of improved protein backbone parameters</article-title><source>Proteins: Structure, Function, and Bioinformatics</source><year>2006</year><volume>65</volume><fpage>712</fpage><lpage>725</lpage><pub-id pub-id-type="doi">10.1002/prot.21123</pub-id><pub-id pub-id-type="pmcid">PMC4805110</pub-id><pub-id pub-id-type="pmid">16981200</pub-id></element-citation></ref><ref id="R64"><label>(64)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abraham</surname><given-names>M</given-names></name><name><surname>Murtola</surname><given-names>T</given-names></name><name><surname>Schulz</surname><given-names>R</given-names></name><name><surname>Pall</surname><given-names>S</given-names></name><name><surname>Smith</surname><given-names>J</given-names></name><name><surname>Hess</surname><given-names>B</given-names></name><name><surname>Lindahl</surname><given-names>E</given-names></name></person-group><article-title>GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers</article-title><source>SoftwareX</source><year>2015</year><volume>1</volume><fpage>19</fpage><lpage>25</lpage></element-citation></ref><ref id="R65"><label>(65)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lindorff-Larsen</surname><given-names>K</given-names></name><name><surname>Piana</surname><given-names>S</given-names></name><name><surname>Palmo</surname><given-names>K</given-names></name><name><surname>Maragakis</surname><given-names>P</given-names></name><name><surname>Klepeis</surname><given-names>JL</given-names></name><name><surname>Dror</surname><given-names>RO</given-names></name><name><surname>Shaw</surname><given-names>DE</given-names></name></person-group><article-title>Improved side-chain torsion potentials for the Amber ff99SB protein force field</article-title><source>Proteins: Structure, Function, and Bioinformatics</source><year>2010</year><volume>78</volume><fpage>1950</fpage><lpage>1958</lpage><pub-id pub-id-type="doi">10.1002/prot.22711</pub-id><pub-id pub-id-type="pmcid">PMC2970904</pub-id><pub-id pub-id-type="pmid">20408171</pub-id></element-citation></ref><ref id="R66"><label>(66)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jorgensen</surname><given-names>WL</given-names></name><name><surname>Chandrasekhar</surname><given-names>J</given-names></name><name><surname>Madura</surname><given-names>JD</given-names></name><name><surname>Impey</surname><given-names>RW</given-names></name><name><surname>Klein</surname><given-names>ML</given-names></name></person-group><article-title>Comparison of simple potential functions for simulating liquid water</article-title><source>The Journal of Chemical Physics</source><year>1983</year><volume>79</volume><fpage>926</fpage><lpage>935</lpage></element-citation></ref><ref id="R67"><label>(67)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Essmann</surname><given-names>U</given-names></name><name><surname>Perera</surname><given-names>L</given-names></name><name><surname>Berkowitz</surname><given-names>ML</given-names></name><name><surname>Darden</surname><given-names>T</given-names></name><name><surname>Lee</surname><given-names>H</given-names></name><name><surname>Pedersen</surname><given-names>LG</given-names></name></person-group><article-title>A smooth particle mesh Ewald method</article-title><source>The Journal of Chemical Physics</source><year>1995</year><volume>103</volume><fpage>8577</fpage><lpage>8593</lpage></element-citation></ref><ref id="R68"><label>(68)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bussi</surname><given-names>G</given-names></name><name><surname>Donadio</surname><given-names>D</given-names></name><name><surname>Parrinello</surname><given-names>M</given-names></name></person-group><article-title>Canonical sampling through velocity rescaling</article-title><source>The Journal of Chemical Physics</source><year>2007</year><volume>126</volume><elocation-id>014101</elocation-id><pub-id pub-id-type="pmid">17212484</pub-id></element-citation></ref><ref id="R69"><label>(69)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berendsen</surname><given-names>HJ</given-names></name><name><surname>Postma</surname><given-names>Jv</given-names></name><name><surname>Van Gunsteren</surname><given-names>WF</given-names></name><name><surname>DiNola</surname><given-names>A</given-names></name><name><surname>Haak</surname><given-names>JR</given-names></name></person-group><article-title>Molecular dynamics with coupling to an external bath</article-title><source>The Journal of chemical physics</source><year>1984</year><volume>81</volume><fpage>3684</fpage><lpage>3690</lpage></element-citation></ref><ref id="R70"><label>(70)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lomize</surname><given-names>AL</given-names></name><name><surname>Todd</surname><given-names>SC</given-names></name><name><surname>Pogozheva</surname><given-names>ID</given-names></name></person-group><article-title>Spatial arrangement of proteins in planar and curved membranes by PPM 3.0</article-title><source>Protein Science</source><year>2022</year><volume>31</volume><fpage>209</fpage><lpage>220</lpage><pub-id pub-id-type="doi">10.1002/pro.4219</pub-id><pub-id pub-id-type="pmcid">PMC8740824</pub-id><pub-id pub-id-type="pmid">34716622</pub-id></element-citation></ref><ref id="R71"><label>(71)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jo</surname><given-names>S</given-names></name><name><surname>Kim</surname><given-names>T</given-names></name><name><surname>Iyer</surname><given-names>VG</given-names></name><name><surname>Im</surname><given-names>W</given-names></name></person-group><article-title>CHARMM-GUI: a web-based graphical user interface for CHARMM</article-title><source>Journal of computational chemistry</source><year>2008</year><volume>29</volume><fpage>1859</fpage><lpage>1865</lpage><pub-id pub-id-type="pmid">18351591</pub-id></element-citation></ref><ref id="R72"><label>(72)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>J</given-names></name><name><surname>Rauscher</surname><given-names>S</given-names></name><name><surname>Nawrocki</surname><given-names>G</given-names></name><name><surname>Ran</surname><given-names>T</given-names></name><name><surname>Feig</surname><given-names>M</given-names></name><name><surname>De Groot</surname><given-names>BL</given-names></name><name><surname>Grubmüller</surname><given-names>H</given-names></name><name><surname>MacKerell</surname><given-names>AD</given-names><suffix>Jr</suffix></name></person-group><article-title>CHARMM36m: an improved force field for folded and intrinsically disordered proteins</article-title><source>Nature methods</source><year>2017</year><volume>14</volume><fpage>71</fpage><lpage>73</lpage><pub-id pub-id-type="doi">10.1038/nmeth.4067</pub-id><pub-id pub-id-type="pmcid">PMC5199616</pub-id><pub-id pub-id-type="pmid">27819658</pub-id></element-citation></ref><ref id="R73"><label>(73)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>MacKerell</surname><given-names>AD</given-names><suffix>Jr</suffix></name><name><surname>Bashford</surname><given-names>D</given-names></name><name><surname>Bellott</surname><given-names>M</given-names></name><name><surname>Dunbrack</surname><given-names>RL</given-names><suffix>Jr</suffix></name><name><surname>Evanseck</surname><given-names>JD</given-names></name><name><surname>Field</surname><given-names>MJ</given-names></name><name><surname>Fischer</surname><given-names>S</given-names></name><name><surname>Gao</surname><given-names>J</given-names></name><name><surname>Guo</surname><given-names>H</given-names></name><name><surname>Ha</surname><given-names>S</given-names></name><collab>others</collab></person-group><article-title>All-atom empirical potential for molecular modeling and dynamics studies of proteins</article-title><source>The journal of physical chemistry B</source><year>1998</year><volume>102</volume><fpage>3586</fpage><lpage>3616</lpage><pub-id pub-id-type="pmid">24889800</pub-id></element-citation></ref><ref id="R74"><label>(74)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parrinello</surname><given-names>M</given-names></name><name><surname>Rahman</surname><given-names>A</given-names></name></person-group><article-title>Polymorphic transitions in single crystals: A new molecular dynamics method</article-title><source>Journal of Applied Physics</source><year>1981</year><volume>52</volume><fpage>7182</fpage><lpage>7190</lpage></element-citation></ref><ref id="R75"><label>(75)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Daura</surname><given-names>X</given-names></name><name><surname>Gademann</surname><given-names>K</given-names></name><name><surname>Jaun</surname><given-names>B</given-names></name><name><surname>Seebach</surname><given-names>D</given-names></name><name><surname>van Gunsteren</surname><given-names>WF</given-names></name><name><surname>Mark</surname><given-names>AE</given-names></name></person-group><article-title>Peptide Folding: When Simulation Meets Experiment</article-title><source>Angewandte Chemie International Edition</source><year>1999</year><volume>38</volume><fpage>236</fpage><lpage>240</lpage></element-citation></ref><ref id="R76"><label>(76)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cock</surname><given-names>PJA</given-names></name><name><surname>Antao</surname><given-names>T</given-names></name><name><surname>Chang</surname><given-names>JT</given-names></name><name><surname>Chapman</surname><given-names>BA</given-names></name><name><surname>Cox</surname><given-names>CJ</given-names></name><name><surname>Dalke</surname><given-names>A</given-names></name><name><surname>Friedberg</surname><given-names>I</given-names></name><name><surname>Hamelryck</surname><given-names>T</given-names></name><name><surname>Kauff</surname><given-names>F</given-names></name><name><surname>Wilczynski</surname><given-names>B</given-names></name><name><surname>de Hoon</surname><given-names>MJL</given-names></name></person-group><article-title>Biopython: freely available Python tools for computational molecular biology and bioinformatics</article-title><source>Bioinformatics</source><year>2009</year><volume>25</volume><fpage>1422</fpage><lpage>1423</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btp163</pub-id><pub-id pub-id-type="pmcid">PMC2682512</pub-id><pub-id pub-id-type="pmid">19304878</pub-id></element-citation></ref><ref id="R77"><label>(77)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Michaud-Agrawal</surname><given-names>N</given-names></name><name><surname>Denning</surname><given-names>EJ</given-names></name><name><surname>Woolf</surname><given-names>TB</given-names></name><name><surname>Beckstein</surname><given-names>O</given-names></name></person-group><article-title>MDAnalysis: A toolkit for the analysis of molecular dynamics simulations</article-title><source>Journal of Computational Chemistry</source><year>2011</year><volume>32</volume><fpage>2319</fpage><lpage>2327</lpage><pub-id pub-id-type="doi">10.1002/jcc.21787</pub-id><pub-id pub-id-type="pmcid">PMC3144279</pub-id><pub-id pub-id-type="pmid">21500218</pub-id></element-citation></ref><ref id="R78"><label>(78)</label><element-citation publication-type="confproc"><person-group person-group-type="author"><name><surname>Richard</surname><given-names>J Gowers</given-names></name><name><surname>Max</surname><given-names>Linke</given-names></name><name><surname>Jonathan</surname><given-names>Barnoud</given-names></name><name><surname>Reddy</surname><given-names>Tyler JE</given-names></name><name><surname>Melo</surname><given-names>Manuel N</given-names></name><name><surname>Seyler</surname><given-names>Sean L</given-names></name><name><surname>Jan</surname><given-names>Domański</given-names></name><name><surname>Dotson</surname><given-names>David L</given-names></name><name><surname>Buchoux</surname><given-names>Sèbastien</given-names></name><name><surname>Kenney</surname><given-names>Ian M</given-names></name><name><surname>Oliver Beckstein</surname><given-names>MD</given-names></name></person-group><source>Analysis: A Python Package for the Rapid Analysis of Molecular Dynamics Simulations</source><conf-name>Proceedings of the 15th Python in Science Conference</conf-name><year>2016</year><fpage>98</fpage><lpage>105</lpage></element-citation></ref><ref id="R79"><label>(79)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trott</surname><given-names>O</given-names></name><name><surname>Olson</surname><given-names>AJ</given-names></name></person-group><article-title>AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading</article-title><source>Journal of Computational Chemistry</source><year>2010</year><volume>31</volume><fpage>455</fpage><lpage>461</lpage><pub-id pub-id-type="doi">10.1002/jcc.21334</pub-id><pub-id pub-id-type="pmcid">PMC3041641</pub-id><pub-id pub-id-type="pmid">19499576</pub-id></element-citation></ref><ref id="R80"><label>(80)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goodsell</surname><given-names>DS</given-names></name><name><surname>Lauble</surname><given-names>H</given-names></name><name><surname>Stout</surname><given-names>CD</given-names></name><name><surname>Olson</surname><given-names>AJ</given-names></name></person-group><article-title>Automated docking in crystallography: analysis of the substrates of aconitase</article-title><source>Proteins: Structure, Function, and Bioinformatics</source><year>1993</year><volume>17</volume><fpage>1</fpage><lpage>10</lpage><pub-id pub-id-type="pmid">8234239</pub-id></element-citation></ref><ref id="R81"><label>(81)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Agarwal</surname><given-names>R</given-names></name><name><surname>Smith</surname><given-names>JC</given-names></name></person-group><article-title>Speed vs Accuracy: Effect on Ligand Pose Accuracy of Varying Box Size and Exhaustiveness in AutoDock Vina</article-title><source>Molecular Informatics</source><year>2023</year><volume>42</volume><elocation-id>2200188</elocation-id><pub-id pub-id-type="pmid">36262028</pub-id></element-citation></ref><ref id="R82"><label>(82)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mysinger</surname><given-names>MM</given-names></name><name><surname>Carchia</surname><given-names>M</given-names></name><name><surname>Irwin</surname><given-names>JJ</given-names></name><name><surname>Shoichet</surname><given-names>BK</given-names></name></person-group><article-title>Directory of useful decoys, enhanced (DUD-E): better ligands and decoys for better benchmarking</article-title><source>Journal of medicinal chemistry</source><year>2012</year><volume>55</volume><fpage>6582</fpage><lpage>6594</lpage><pub-id pub-id-type="doi">10.1021/jm300687e</pub-id><pub-id pub-id-type="pmcid">PMC3405771</pub-id><pub-id pub-id-type="pmid">22716043</pub-id></element-citation></ref><ref id="R83"><label>(83)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lagarde</surname><given-names>N</given-names></name><name><surname>Ben Nasr</surname><given-names>N</given-names></name><name><surname>Jèrèmie</surname><given-names>A</given-names></name><name><surname>Guillemain</surname><given-names>H</given-names></name><name><surname>Laville</surname><given-names>V</given-names></name><name><surname>Labib</surname><given-names>T</given-names></name><name><surname>Zagury</surname><given-names>JF</given-names></name><name><surname>Montes</surname><given-names>M</given-names></name></person-group><article-title>NRLiSt BDB, the manually curated nuclear receptors ligands and structures benchmarking database</article-title><source>Journal of medicinal chemistry</source><year>2014</year><volume>57</volume><fpage>3117</fpage><lpage>3125</lpage><pub-id pub-id-type="pmid">24666037</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="F1" position="float"><label>Figure 1</label><caption><title>Overview of bAIes.</title><p>bAIes is a Bayesian inference framework to integrate state-of-the-art molecular mechanics force fields (<italic>top left</italic>) with pairwise distograms reflecting the confidence in AlphaFold2 predictions (<italic>bottom left</italic>) to refine protein targets models and improve docking of large small molecule libraries (<italic>right</italic>).</p></caption><graphic xlink:href="EMS207036-f001"/></fig><fig id="F2" position="float"><label>Figure 2</label><caption><title>Structural accuracy of ligand binding pockets.</title><p>Assessment of structural accuracy of ligand binding pockets for 3 selected systems: (<bold>a</bold>) estrogen receptor (PDB code 3ERD), (<bold>b</bold>) purine nucleoside phosphorylase (PDB code 3BGS), and (<bold>c</bold>) cyclin-dependent kinase (PDB code 1H00). For each system: (<italic>top</italic>) AF model of the protein, colored according to pLDDT, with inset highlighting the binding site residues (pLDDT-colored licorice) and the ligand positioned as in the corresponding X-ray structure (pink licorice); (<italic>middle</italic>) distributions of binding pocket <italic>C</italic><sub><italic>β</italic></sub>-RMSD from the reference experimental <italic>holo</italic> conformation, for bAIes (blue) and MD (orange) simulations. RMSD of the AF model is represented with a gray dashed line; (<italic>bottom</italic>) RMSD distributions as in (<italic>middle</italic>) calculated from the closest experimental <italic>holo</italic> conformation. In both (<italic>middle</italic>) and (<italic>bottom</italic>), orange and blue stars mark whether MD and bAIes, respectively, sample pocket conformations closer to the experimental one than AF. Raw normalized histograms are represented by bars, kernel density estimations as solid lines.</p></caption><graphic xlink:href="EMS207036-f002"/></fig><fig id="F3" position="float"><label>Figure 3</label><caption><title>Structural accuracy of native ligand docking poses.</title><p><bold>(a)</bold> Percentage of docking successes across the entire benchmark set of 15 systems using bAIes (blue), MD (orange), AF (gray) and experimental (pink) structures. <bold>(b)</bold> For each system in the benchmark: (<italic>top</italic>) cartoon representation of the experimental <italic>holo</italic> structure, with highlight on the native ligand (pink); (<italic>bottom</italic>) ligand RMSDs with respect to experimental structure obtained from docking against bAIes, MD, AF, and experimental structures. Coloring as in <bold>(a)</bold>. Systems that resulted in a successful dock by either bAIes, MD or AF models are marked with the PDB name in bold. <bold>(c)</bold> Diagram illustrating the overlap among successful cases of docking by bAIes, MD, and AF models. Numbers represent unique and shared successes among the models; coloring as in <bold>(a). (d)</bold> Correlation between ligand RMSDs when docking against AF models and either bAIes (blue dots) or MD models (orange dots). The ligand RMSDs values corresponding to the cutoff for successful docking (2Å) are indicated by gray dashed lines.</p></caption><graphic xlink:href="EMS207036-f003"/></fig><fig id="F4" position="float"><label>Figure 4</label><caption><title>Virtual screening of small molecule libraries.</title><p>Assessment of the ability of different models to discriminate between actives and decoys in large small molecule libraries, for 3 selected systems: (<italic>left</italic>) estrogen receptor (PDB code 3ERD), (<italic>center</italic>) purine nucleoside phosphorylase (PDB code 3BGS), and (<italic>right</italic>) cyclin-dependent kinase (PDB code 1H00). (<bold>a</bold>) AF model of the protein target (colored according to pLDDT), with binding pocket highlighted by a coral colored circle, alongside a pie chart with the number of actives (green) and decoys (beige) ligands present in the corresponding library. (<bold>b</bold>) ROC (upper diagonal) and pROC (lower diagonal) curves obtained with the bAIes (blue), MD (orange), AF (gray dashed), and experimental <italic>holo</italic> structures (pink dashed). The random classifier is represented by black dotted lines for ROC and pROC. (<bold>c-d</bold>) Number of unique active ligands identified by (<bold>c</bold>) bAIes and AF models, as well as (<bold>d</bold>) bAIes and MD models, as a function of the number of top ranked ligands. Kernel density estimations are represented by solid lines; colors as in (<bold>b</bold>).</p></caption><graphic xlink:href="EMS207036-f004"/></fig><table-wrap id="T1" orientation="portrait" position="float"><label>Table 1</label><caption><title>Binding pocket structural accuracy.</title><p>Binding pocket RMSD of the AF model and representatives of the top 3 clusters found by MD and bAIes simulations with respect to the reference (<italic>ref</italic>.) as well as closest (<italic>best</italic>) experimental <italic>holo</italic> structures for the 3 systems used in the virtual screening.</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="center" style="border-top:solid 1.5px #000000"/><th valign="top" align="center" style="border-top:solid 1.5px #000000;border-left:solid 1px #000000"/><th valign="top" align="center" colspan="3" style="border-top: 1.5px solid #000000;border-left: 1px solid #000000">AF model</th><th valign="top" align="center" colspan="3" style="border-top:solid 1.5px #000000;border-left:solid 1px #000000">MD top 3 clusters</th><th valign="top" align="center" colspan="3" style="border-top:solid 1.5px #000000;border-left:solid 1px #000000">bAIes top 3 clusters</th></tr><tr><th valign="top" align="left">System</th><th valign="top" align="left" style="border-left:solid 1px #000000">PDB ref. holo</th><th valign="top" align="left" style="border-left: 1px solid #000000">RMSD ref. holo<break/>[Å]</th><th valign="top" align="left">PDB best holo</th><th valign="top" align="left">RMSD best holo<break/>[Å]</th><th valign="top" align="left" style="border-left:solid 1px #000000">RMSD ref. holo<break/>[Å]</th><th valign="top" align="left">PDB best holo</th><th valign="top" align="left">RMSD best holo<break/>[Å]</th><th valign="top" align="left" style="border-left:solid 1px #000000">RMSD ref. holo<break/>[Å]</th><th valign="top" align="left">PDB best holo</th><th valign="top" align="left">RMSD best holo<break/>[Å]</th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="3" style="border-top: 1px solid #000000">Estrogen receptor <italic>α</italic></td><td valign="top" align="left" rowspan="3" style="border-top: 1px solid #000000;border-left: 1px solid #000000">3ERD</td><td valign="top" align="left" rowspan="3" style="border-top: 1px solid #000000;border-left: 1px solid #000000">0.85</td><td valign="top" align="left" rowspan="3" style="border-top: 1px solid #000000">1GWR</td><td valign="top" align="left" rowspan="3" style="border-top: 1px solid #000000">0.39</td><td valign="top" align="left" style="border-top: 1px solid #000000;border-left: 1px solid #000000">0.91</td><td valign="top" align="left" style="border-top: 1px solid #000000">1GWR</td><td valign="top" align="left" style="border-top: 1px solid #000000">0.65</td><td valign="top" align="left" style="border-top: 1px solid #000000;border-left: 1px solid #000000">0.92</td><td valign="top" align="left" style="border-top: 1px solid #000000">1GWR</td><td valign="top" align="left" style="border-top: 1px solid #000000">0.46</td></tr><tr><td valign="top" align="left" style="border-left: 1px solid #000000">0.82</td><td valign="top" align="left">1GWR</td><td valign="top" align="left">0.74</td><td valign="top" align="left" style="border-left: 1px solid #000000">0.97</td><td valign="top" align="left">1GWR</td><td valign="top" align="left">0.45</td></tr><tr><td valign="top" align="left" style="border-left: 1px solid">0.98</td><td valign="top" align="left">1GWR</td><td valign="top" align="left">0.77</td><td valign="top" align="left" style="border-left: 1px solid">1.00</td><td valign="top" align="left">1GWR</td><td valign="top" align="left">0.49</td></tr><tr><td valign="top" align="left" rowspan="3">Purine nucleoside<break/>phosphorylase</td><td valign="top" align="left" rowspan="3" style="border-left: 1px solid #000000">3BGS</td><td valign="top" align="left" rowspan="3" style="border-left: 1px solid #000000">0.92</td><td valign="top" align="left" rowspan="3">1RT9</td><td valign="top" align="left" rowspan="3">0.79</td><td valign="top" align="left" style="border-left: 1px solid #000000">2.47</td><td valign="top" align="left">1PF7</td><td valign="top" align="left">1.92</td><td valign="top" align="left" style="border-left: 1px solid #000000">1.06</td><td valign="top" align="left">1RT9</td><td valign="top" align="left">0.92</td></tr><tr><td valign="top" align="left" style="border-left:solid 1px #000000">2.10</td><td valign="top" align="left">2Q70</td><td valign="top" align="left">1.74</td><td valign="top" align="left" style="border-left:solid 1px #000000">1.02</td><td valign="top" align="left">1RT9</td><td valign="top" align="left">0.89</td></tr><tr><td valign="top" align="left" style="border-left: 1px solid">2.32</td><td valign="top" align="left">2Q70</td><td valign="top" align="left">2.20</td><td valign="top" align="left" style="border-left: 1px solid">1.05</td><td valign="top" align="left">1RT9</td><td valign="top" align="left">0.92</td></tr><tr><td valign="top" align="left" rowspan="3" style="border-bottom: 1px solid #000000">Cyclin- dependent<break/>kinase</td><td valign="top" align="left" rowspan="3" style="border-left: 1px solid #000000;border-bottom: 1px solid #000000">1H00</td><td valign="top" align="left" rowspan="3" style="border-left: 1px solid #000000;border-bottom: 1px solid #000000">5.37</td><td valign="top" align="left" rowspan="3" style="border-bottom: 1px solid #000000">3TI1</td><td valign="top" align="left" rowspan="3" style="border-bottom: 1px solid #000000">0.69</td><td valign="top" align="left" style="border-left: 1px solid #000000">5.48</td><td valign="top" align="left">2VTN</td><td valign="top" align="left">0.95</td><td valign="top" align="left" style="border-left: 1px solid #000000">5.29</td><td valign="top" align="left">2VTN</td><td valign="top" align="left">0.79</td></tr><tr><td valign="top" align="left" style="border-left: 1px solid">5.43</td><td valign="top" align="left">1WCC</td><td valign="top" align="left">0.90</td><td valign="top" align="left" style="border-left: 1px solid">5.28</td><td valign="top" align="left">2VTN</td><td valign="top" align="left">0.75</td></tr><tr><td valign="top" align="left" style="border-left: 1px solid #000000;border-bottom: 1.5px solid">5.41</td><td valign="top" align="left" style="border-bottom: 1.5px solid">1WCC</td><td valign="top" align="left" style="border-bottom: 1.5px solid">1.16</td><td valign="top" align="left" style="border-left: 1px solid #000000;border-bottom: 1.5px solid">5.40</td><td valign="top" align="left" style="border-bottom: 1.5px solid">3TI1</td><td valign="top" align="left" style="border-bottom: 1.5px solid">0.90</td></tr></tbody></table></table-wrap><table-wrap id="T2" orientation="portrait" position="float"><label>Table 2</label><caption><title>Virtual screening performances with experimental, AF, MD, and bAIes structures.</title><p>Area under the ROC curve (ROC-AUC) and pROC curve (pROC-AUC) for the 3 systems used in the virtual screening.</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="left" style="border-top: 1.5px solid"/><th valign="top" align="center" colspan="2" style="border-top: 1.5px solid #000000">3ERD</th><th valign="top" align="center" colspan="2" style="border-top: 1.5px solid #000000;border-left: 1px solid #000000">3BGS</th><th valign="top" align="center" colspan="2" style="border-top: 1.5px solid #000000;border-left: 1px solid #000000">1H00</th></tr><tr><th valign="top" align="left"/><th valign="top" align="right">ROC-AUC</th><th valign="top" align="right">pROC-AUC</th><th valign="top" align="right" style="border-left: 1px solid">ROC-AUC</th><th valign="top" align="right">pROC-AUC</th><th valign="top" align="right" style="border-left: 1px solid">ROC-AUC</th><th valign="top" align="right">pROC-AUC</th></tr></thead><tbody><tr><td valign="top" align="right" style="border-top: 1px solid #000000">exp</td><td valign="top" align="right" style="border-top: 1px solid #000000">0.73</td><td valign="top" align="right" style="border-top: 1px solid #000000">1.28</td><td valign="top" align="right" style="border-top: 1px solid #000000;border-left: 1px solid #000000">0.89</td><td valign="top" align="right" style="border-top: 1px solid #000000">1.47</td><td valign="top" align="right" style="border-top: 1px solid #000000;border-left: 1px solid #000000">0.74</td><td valign="top" align="right" style="border-top: 1px solid #000000">0.97</td></tr><tr><td valign="top" align="right">AF</td><td valign="top" align="right">0.74</td><td valign="top" align="right">1.21</td><td valign="top" align="right" style="border-left: 1px solid">0.84</td><td valign="top" align="right">1.08</td><td valign="top" align="right" style="border-left: 1px solid">0.7</td><td valign="top" align="right">0.79</td></tr><tr><td valign="top" align="right">MD</td><td valign="top" align="right">0.71</td><td valign="top" align="right">1.03</td><td valign="top" align="right" style="border-left: 1px solid">0.77</td><td valign="top" align="right">0.8</td><td valign="top" align="right" style="border-left: 1px solid">0.71</td><td valign="top" align="right">0.81</td></tr><tr><td valign="top" align="right" style="border-bottom: 1.5px solid">bAIes</td><td valign="top" align="right" style="border-bottom: 1.5px solid">0.75</td><td valign="top" align="right" style="border-bottom: 1.5px solid">1.23</td><td valign="top" align="right" style="border-left: 1px solid #000000;border-bottom: 1.5px solid">0.86</td><td valign="top" align="right" style="border-bottom: 1.5px solid">1.16</td><td valign="top" align="right" style="border-left: 1px solid #000000;border-bottom: 1.5px solid">0.75</td><td valign="top" align="right" style="border-bottom: 1.5px solid">0.94</td></tr></tbody></table></table-wrap></floats-group></article>